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The primary aim of this thesis was the evaluation of the perfusion of normal organs in cats 
using contrast-enhanced ultrasound (CEUS), to serve as a reference for later clinical 
studies. Little is known of the use of CEUS in cats, especially regarding its safety and the 
effects of anesthesia on the procedure, thus, secondary aims here were to validate the 
quantitative analysing method, to investigate the biological effects of CEUS on feline 
kidneys, and to assess the effect of anesthesia on splenic perfusion in cats undergoing 
CEUS.   
The studies were conducted on healthy, young, purpose-bred cats. CEUS of the liver, 
left kidney, spleen, pancreas, small intestine, and mesenteric lymph nodes was performed 
to characterize the normal perfusion of these organs on ten anesthetized, male cats. To 
validate the quantification method, the effects of placement and size of the region of 
interest (ROI) on perfusion parameters were investigated using CEUS: Three separate sets 
of ROIs were placed in the kidney cortex, varying in location, size, or depth. The 
biological effects of CEUS on feline kidneys were estimated by measuring urinary 
enzymatic activities, analyzing urinary specific gravity, pH, protein, creatinine, albumin, 
and sediment, and measuring plasma urea and creatinine concentrations before and after 
CEUS. Finally, the impact of anesthesia on contrast enhancement of the spleen was 
investigated by imaging cats with CEUS first awake and later under anesthesia on separate 
days.  
Typical perfusion patterns were found for each of the studied organs. The liver had a 
gradual and more heterogeneous perfusion pattern due to its dual blood flow and close 
proximity to the diaphragm. An obvious and statistically significant difference emerged in 
the perfusion between the kidney cortex and medulla. Enhancement in the spleen was very 
heterogeneous at the beginning of imaging, indicating focal dissimilarities in perfusion. 
No significant differences emerged in the perfusion parameters between the pancreas, 
small intestine, and mesenteric lymph nodes. 
The ROI placement and size were found to have an influence on the quantitative 
measurements of CEUS. Increasing the depth or the size of the ROI decreased the peak 
intensity value significantly, suggesting that where and how the ROI is placed does matter 
in quantitative analyses. 
A significant increase occurred in the urinary N-acetyl-β-D-glucosaminidase (NAG) to 
creatinine ratio after CEUS. No changes were noted in the serum biochemistry profile 
after CEUS, with the exception of a small decrease in blood urea concentration. The 
magnitude of the rise in the NAG/creatinine ratio was, however, less than the circadian 
variation reported earlier in healthy cats. Thus, the changes observed in the laboratory 
values after CEUS of the left kidney did not indicate any detrimental effects in kidneys. 
Heterogeneity of the spleen was observed to be less and time of first contrast 
appearance earlier in nonanesthetized cats than in anesthetized ones, suggesting that 
anesthesia increases heterogeneity of the feline spleen in CEUS. 
In conclusion, the results suggest that CEUS can be used also in feline veterinary 
patients as an additional diagnostics aid. The perfusion patterns found in the imaged 





the heterogeneous perfusion pattern in the cat spleen. Differences in the perfusion between 
organs corresponded with physiology. Based on the results, estimation of focal perfusion 
defects of the spleen in cats should be performed with caution and after the disappearance 
of the initial heterogeneity, especially in anesthetized or sedated cats. Finally, these results 
indicate that CEUS can be used safely to analyze kidney perfusion also in cats.  
Future clinical studies are needed to evaluate the full potential of CEUS in feline 
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Ultrasonography has been commonly used in veterinary medicine to image the 
architecture of abdominal organs. Ultrasound is considered a good, easy to perform and 
non-invasive imaging modality in diagnosing various diseases. Blood scatters poorly 
compared with tissues in conventional ultrasound. Therefore, Doppler techniques have 
been used to analyze blood flow (Rubin et al., 1994). However, Doppler cannot detect 
flow of a low volume or velocity, or flow from unfavorable angles or in deep tissues 
(Rubin et al., 1994; Taylor et al., 1996; Nilsson et al., 1997). Furthermore, Doppler is very 
sensitive to motion artifacts, making it sometimes difficult to use with awake or panting 
animals. The scattering ability of the blood can be enhanced with gas-containing 
microbubbles called ultrasound contrast agents (USCAs). Contrast-enhanced ultrasound 
(CEUS) is free from the above-mentioned restrictions of Doppler imaging and even very 
small vessels, such as capillary level microcirculation, can be detected (Greis, 2004). 
CT and MRI have long been the golden standard for imaging malignancies in human 
medicine (Villa et al., 1995). The possible side-effects, including adverse or allergic 
reactions and potential nephrotoxicity of these iodine- and gadolinium-containing contrast 
agents, limit their use particularly in patients with kidney disease (Mehran et al., 2006; 
Persson et al., 2006; Perazella, 2008). The use of CT and MRI for evaluation of masses 
and tumors has been studied to a certain extent in veterinary medicine (Le Blanc et al., 
2007; Ohlerth et al., 2007b). However, detailed studies from specific CT or MRI changes 
in abdominal organs with numerous disease processes are still lacking. In addition to the 
possible toxicities of CT and MRI contrast agents, the need for anesthesia further limits 
the use of both CT and MRI in veterinary patients. 
CEUS is based on highly reflecting microbubbles that give contrast between the 
surrounding tissues and blood (Calliada et al., 1998). The echoes from the blood are 
normally too low to be detected with basic ultrasound and appear anechoic in relation to 
the surrounding hypoechoic soft tissues. With USCAs, the echoes returning from the 
blood are enhanced so that even tissue parenchymal microcirculation can be detected. For 
the detection of real-,time perfusion in the tissues, a specialized contrast-specific 
ultrasound technique (eg. harmonic and coded imaging or phase amplitude modulation) is 
needed to visualize returning echoes from the microbubbles/blood, allowing detection of 
tissue microcirculation (Calliada et al., 1998). Contrast agents are therefore useful for 
more accurate detection and characterization of many intra-abdominal diseases, including 
liver nodules, kidney lesions, metastases, trauma and infarction. 
CEUS was first introduced to human medicine as a new method for detecting 
congenital cardiac defects (Drobac et al., 1983) and detecting and characterizing focal 
changes in the liver (Nicolau et al., 2004). Nowadays, CEUS is used for more detailed 
detection and characterization of focal changes in perfusion in various organs, including 
the spleen (Görg et al., 2007), kidneys (Bertolotto et al., 2008), pancreas (D’Onofrio et al., 
2007), prostate (Karaman et al., 2005), mammary gland (Chaudhari et al., 2000), adrenals 
(Friedrich-Rust et al., 2008), and lymph nodes (Bude, 2004). Liver lesions can be 







CEUS has been proven to be a safe and minimally invasive diagnostic tool for human 
(Blomley et al., 2007; Piscaglia et al., 2006) and veterinary (Ziegler et al., 2003; Nyman et 
al., 2005; Rademacher et al., 2008) patients. The only current accepted clinical indication 
for using contrast ultrasound in veterinary medicine is the detection and characterization 
of lesions in the liver, spleen, and lymph nodes in dogs (O’Brien et al., 2004a; Salwei et 
al., 2005; Kutara et al., 2006; O’Brien,  2007; Ohlerth et al., 2008; Rossi et al., 2008; 
Ivancic  et al., 2009). The lack of baseline studies and limited knowledge about the effect 
of anesthesia on CEUS, and the behavior of USCAs in cats, including possible harmful 
effects on kidney function,  have restricted the use of the tool for clinical feline patients.  
The aim of this thesis is to provide evidence-based knowledge of the use of CEUS in 
cats, and to serve as a background for future clinical studies. The use of CEUS is expected 






3. Review of the literature 
3.1. Contrast-enhanced ultrasound (CEUS) 
 
CEUS is based on enhancing the returning echoes from the blood by USCAs over the 
tissue backscattering. Both the sensitivity and specificity of ultrasound imaging can be 
increased with USCAs. An increase in the signal intensity can be detected in conventional 
B-mode ultrasound as a slight image enhancement (Uhlendorf, 1994; Bouakaz et al., 
1998). The contrast enhancement is detected even better for a brief moment with Doppler 
imaging or in real time with contrast-specific detection modes (Frush et al., 1995). The 
Doppler-method is today used mainly in transcranial imaging to improve the signal-to-
noise ratio, when the ultrasound signal is attenuated by the skull (Seidel et al., 2000; 
Seidel et al., 2009). Most of the CEUS studies are currently performed utilizing contrast-
specific software. These techniques exploit the specific acoustic properties of USCA 
microbubbles and enable continuous real-time imaging of tissue parenchymal blood flow, 
by suppressing signals from tissues, and thus, intensifying the signals from USCAs (de 
Jong et al., 2001).  
 
3.1.1. Signal processing 
 
Contrast-specific software is based on suppressing the signals from the background tissues 
and enhancing the signals from the microbubbles, giving good contrast between the blood 
and tissue. Several techniques have been developed for signal processing to selectively 
collect information from the non-linear microbubble oscillations; these include second 
harmonic imaging (Schrope et al., 1993), pulse inversion harmonic imaging (Simpson et 
al., 1999), and cadence-contrast pulse sequencing and power (amplitude) modulation (de 
Jong et al., 2001; Thomas et al., 2009).  
The behavior of microbubbles is affected by ultrasound scanning parameters, such as 
resonance frequency, pulse repetition frequency, number and location of focal zones, and 
acoustic power, and by the properities of the filling gas, damping coefficients, and shell 
properties (de Jong et al., 1994a; 1994b; Hoff, 1996; Moran et al., 1998; Hoff et al., 2000; 
Uhlendorf et al., 2000; de Jong et al., 2002; Emmer et al., 2007; Whittingham et al., 2007; 
Yeh et al., 2008). Local acoustic power is the principal parameter directing the behavior of 
microbubbles (Emmer et al., 2007; Yeh et al., 2008). The local acoustic power depends 
mainly on the output power of the ultrasound system, the transmission frequency, and the 
attenuation of the ultrasound beam with depth (Whittingham et al., 2007; Yeh et al., 
2008). Depending on the acoustic power, different interactions between the incident 
ultrasound beam and the microbubbles take place, including scattering, resonance and 
microbubble destruction (de Jong et al., 1994a; 1994b; Raichlen, 2001; Sboros et al., 
2003; Emmer et al., 2007; de Jong et al., 2007). 
The output power combined with transmit frequency is reflected by the mechanical 






exposed to ultrasound pulses (Raichlen, 2001; Bouakaz et al., 2007). MI also gives an 
indication of the likelihood of bubble destruction: the higher the MI, the greater its 
destructive properties and the poorer the contrast effects (Raichlen, 2001; de Jong et al., 
2002). However, these parameters are not directly comparable between different 
ultrasound systems because of differences in technology of ultrasound equipment and 
companies. 
Contrast-specific detection modes utilize the interaction of the microbubbles with 
ultrasound waves. This interaction depends on microbubble size, shell flexibility, 
transducer frequency, and MI (Church et al., 1995; Frinking et al., 1998; de Jong et al., 
2000; Uhlendorf et al., 2000; Bouakaz et al., 2007; Emmer et al., 2007; van der Meer et 
al., 2007; Yeh et al., 2008). At very low acoustic power the oscillation is symmetrical and 
the change in size is equal in both compression and expansion (Uhlendorf, 1994; van Liew 
et al., 1995; Hoff, 1996). When acoustic power is increased, the bubbles start to expand 
more than compress, and thus, the oscillations become asymmetric (Hoff, 1996).  These 
asymmetric signals emitted by microbubbles can be detected at transmitted (fundamental) 
ultrasound frequency and at multiples of this frequency, e.g. the second harmonic at 
double the transmitted frequency (de Jong et al., 1994a; 1994b). 
This separation of harmonic microbubble signals from the fundamental linear signals 
arising from tissue results in loss of image resolution. Furthermore, the tissues can also 
produce harmonic signals with use of high acoustic power (Dong et al., 1999; Uhlendorf 
et al., 2000). Distinguishing between tissue and microbubble harmonic signals is 
challenging even with contrast-specific detection modes. However, the newer, second- and 
third generation microbubbles with an elastic shell can be made to oscillate 
asymmetrically with very low acoustic powers, enabling the separation of microbubble 
and tissue harmonics and a reduced signal-to-noise ratio (Ward et al., 1997; Wu et al., 
1998; Uhlendorf et al., 2000). Furthermore, with low acoustic power (low MI), real time 
scanning is made possible, allowing dynamic perfusion studies. 
 
3.1.2. Use in human medicine 
 
CEUS is used in human medicine for more detailed detection and characterization of focal 
changes in perfusion in several organs, including the heart (Kitzman et al., 2000), liver 
(Nicolau et al., 2004), spleen (Görg et al., 2007), kidneys (Nilsson, 2004), pancreas 
(Kitano et al., 2004), prostate (Karaman et al., 2005), mammary gland (Chaudhari et al. 
2000), adrenals (Friedrich-Rust et al., 2008), and lymph nodes (Bude, 2004). It is also 
used in detecting pathological changes affecting large vessels and in diagnosing 
abdominal trauma (Leen et al., 2004; Martegani et al., 2004; Thorelius, 2004). CEUS is 
not only important in detecting the aforementioned perfusional changes and aiding 
diagnostic work in suspicion of neoplastic, traumatic, or necrotic lesions, but also in the 
treatment and monitoring of cancer (Leen et al., 2004; Solbiati et al., 2004). Most studies 
have, however, been focused on the liver. Because of the dual blood flow in the liver, the 
differentiation of liver lesions as benign or malignant can be made with high accuracy 
with the help of CEUS, even up to the histological level (Nicolau et al., 2004; Lee, 2005; 







3.1.3. Use in veterinary medicine 
 
In veterinary medicine, CEUS is currently indicated for clinical use in the detection and 
characterization of lesions in the liver, spleen, prostate, and lymph nodes, and in detection 
of kidney infarctions and lesions in dogs (O’Brien et al., 2004a; Salwei et al., 2005; 
Kutara et al., 2006; Ohlerth et al., 2008; Rossi et al., 2008; 2010; Ivancic et al., 2009; 
Kanemoto et al., 2009; Nakamura et al., 2009; 2010; Haers et al., 2010; Vignoli et al., 
2010). For example, in the liver malignant tumors enhance early with CEUS due to mainly 
arterial blood flow, whereas benign tumors are usually uniformly isoechoic relative to the 
surrounding liver (O’Brien et al., 2004a). In other organs, such as the kidneys and spleen, 
lesions are mainly classified as hyper-, iso-, or hypovascular, based on how they enhance 
in relation to the surrounding parenchymal tissue (Ohlerth et al., 2008; Haers et al., 2010). 
The diagnostic possibilities of CEUS in veterinary medicine are constantly increasing. 
Studies are available of CEUS of the pancreas, adrenal gland, and testicles (Johnson-
Neitman et al. 2007; Pey et al., 2010; Volta et al., 2010). However, no studies have been 
reported of diffuse organ diseases and CEUS in veterinary medicine, and only a few in 
human medicine (Rahbin et al., 2008, Li et al., 2010). Several studies have been conducted 
with healthy dogs to investigate normal perfusion in various organs (liver, spleen, kidneys, 
prostate, stomach, small intestine) (Ziegler et al., 2003; Nyman et al., 2005; Kamino et al., 
2006; Ohlerth et al., 2007a; Waller et al., 2007; Nakamura  et al., 2009, Russo et al., 2009; 
Vignoli et al. 2010; Bigliardi et al., 2011; Jiménez et al., 2011), but little is known about 
the effect of anesthesia on CEUS (Nyman et al., 2005). In cats, however, only a few 
studies have been published on the use of CEUS; in evaluating the normal perfusion of 
kidneys in healthy cats (Kinns et al., 2010) and in diagnosing pancreatic disease using 
contrast-enhanced power and color Doppler techniques (Rademacher et al.,  2008). 
 
3.1.4. Quantification of perfusion 
 
In CEUS, the perfusion of a tissue or organ is assessed quantitatively from time-intensity 
curves (TICs) in a selected region of interest (ROI).  The shape of the TIC has been shown 
to reflect the vascular structure of the imaged organ (Li et al., 2006; Metoki et al., 2006). 
Therefore, the tissue perfusion can be estimated with CEUS, as concentration of 
microbubbles in blood flow (signal intensity), indicating quantity of blood flow (Wei, 
2001; Lucidarme et al., 2003). In quantitative analyses, detailed information of signal 
intensity vs. time can be obtained from a selected ROI, resulting in several perfusion 
parameters, such as contrast arrival time (AT), time to peak intensity (TTPinj), and peak 
intensity (PI), acquired from the generated TIC (Du et al., 2008; Fleischer et al., 2008). 
The size and location of an ROI have been shown to have an effect on the intensity values 
obtained in experimental and theoretical models (Claudon et al., 1999; Taylor et al., 1999; 
Schlosser et al., 2001; Sonne et al., 2003; Mulé et al., 2008). The main clinical use of 
perfusion parameters is assessment of blood flow changes in an organ or tissue in real-
time (Quaia et al., 2006). This aids in distinguishing between normal and abnormal flow, 






The relationship between microbubble concentration and signal intensity has been 
found to vary depending on the concentration (Taylor et al., 1996; Forsberg et al., 2001; 
Wei, 2001; Li et al. 2005).  The relationship between bubble concentration and signal 
intensity is linear with low microbubble concentrations, becoming exponential with higher 
concentrations (Skyba et al., 1994; Forsberg et al., 2001). Besides microbubble 
concentration, the size of the activated microbubbles in the circulation has an effect on the 
intensity detected (Porter et al., 1997; Emmer et al., 2007; Goertz et al., 2007). 
Unfortunately, several other factors can impair accurate perfusion quantification, the most 
important of which are motion artifact and shadowing effect resulting from signal 
intensity attenuation caused by microbubbles (Li et al., 2006; Mulé et al., 2007). Motion 
artifact can be detected in the image as local changes in signal intensity with 
replenishment of microbubbles or movement of the ROI outside the targeted tissue. 
Motion artifact can also be seen in the TIC as false peaks and troughs. For an accurate 
quantification of perfusion, motion artifact needs to be taken into account and removed 
before analyses. Attenuation can be seen in the image as decreased signal intensity in the 
far-field either quantitatively or, if high enough, visually.  
Besides having a direct impact on perfusion quantification by influencing microbubble 
backscattering, microbubble concentration has an effect on the attenuation of the 
ultrasound (Porter et al., 1997; Forsberg et al., 2001; Li et al., 2005). For quantitative 
measurements, sufficiently low microbubble concentrations, i.e. a linear relationship 
between microbubble and signal intensity, are needed (Forsberg et al., 2001; Wei, 2001; 
Rognin et al., 2008). When the concentration exceeds this, the tissue signal intensity starts 
to approach the signal intensity of a blood pool such as large vessels, and the relationship 
becomes exponential (Wei, 2001). Microbubble saturation must therefore be avoided to 
enable quantification (Wei, 2001; Li et al., 2005; Rognin et al., 2008). However, there are 
also multiple other factors influencing the attenuation in CEUS in vivo, such as bubble 
size and shell type (Emmer et al., 2007), acoustic pressure (Emmer et al., 2007; 2009), and 
transducer frequency (Yeh et al., 2008), making image optimization challenging. 
Furthermore, bubble size and behavior have been reported to change with varying 
injection techniques (Talu et al., 2008; Kaya et al., 2009), vessel type and size (Qin et al., 
2007), tissue temperature (Mulvana et al., 2010), and over time (Goertz et al., 2007).  
Whether bolus injection technique or constant infusion is better for quantifying 
perfusion is under debate (Wei, 2001; Okada et al., 2005; Kaya et al., 2009; Su et al., 
2009).  Contrast enhancement has been reported to last longer, but to be less marked with 
the infusion technique (Okada et al., 2005). However, no difference appeared in the lesion 
to liver contrast between the two techniques in a previous study (Okada et al., 2005). Due 
to less intense enhancement with infusion, less attenuation can be expected in the far-field 
of the image, and it may also be customized with titrating the USCA dose (Wei, 2001). On 
the other hand, changes in the spatial distribution of the microbubbles have been reported 
with the infusion technique without specific mixing devices over time (Kaya et al., 2009). 
Furthermore, the different enhancement phases in the liver are not detected with infusion, 
and thus, dynamic lesion characterization can be impaired, especially with hypervascular 






3.2. Ultrasound contrast agents (USCAs) 
3.2.1. Physical properties of USCAs 
 
The development of USCAs began decades ago, after an incidental finding during 
echocardiographic examination, when saline was injected intra-cardially in a human 
patient and an enhancement of the ultrasound signal was observed during the injection due 
to air bubbles within the saline (Gramiak et al., 1968). Since then, developments in 
USCAs have been dramatic. The future of USCAs is in molecular-level imaging, targeted 
CEUS, and drug delivery. 
USCAs consist of gas-filled microbubbles encapsulated by a shell of different 
composition. The gas inside the microbubbles is stable, low-soluble, biologically inert, 
and non-toxic (Lester at al., 1950; Morel et al., 2000; FDA, 2001; EMEA, 2005; Bouakaz 
et al., 2007). The size of the microbubbles corresponds to the size of red blood cells (2-8 
µm). Microbubbles are therefore big enough (high molecular weight) not to diffuse to the 
extracellular space, but small enough to pass the lung capillary system without being 
filtered out of the body system (Morel et al., 2000; Wheatley, 2001; Bouakaz et al.,  
2007). The size of the microbubbles is smaller than the ultrasound beam wavelength, and 
therefore, microbubbles behave as scattering reflectors. The large difference in acoustic 
impedance between the gas-containing microbubbles and the surrounding fluid (blood) 
improves the scattering reflector ability of the microbubbles (Cosgrove, 1997; Arditi et al., 
1997; Moran et al., 2000; Frinking et al., 2001; de Jong et al., 2002). These special 
properties of the microbubbles keep them unchanged in cardio-pulmonary circulation 
(Morel et al., 2000; Bouakaz et al., 2007), producing a marked increase (75%) in image 
contrast and systemic enhancement of macro- and microvasculature relative to basic non-
contrast-ultrasound (Pace et al., 1997; Girard et al., 2000). 
USCAs are mainly administered intravenously (iv), although they can be used as a 
direct injection as well, e.g. into the urinary bladder to detect ureteral reflux (Darge et al., 
2002). After an iv administration, microbubbles stay actively within the vascular 
compartment for several minutes (Morel et al., 2000). In general, microbubbles do not 
cross the endothelium, unlike contrast agents used in CT- and MRI studies, and therefore, 
USCAs are considered true blood pool agents (Bauer et al., 2003; Greis, 2004). A 
previously used USCA, Levovist®, however, stayed in the liver and spleen parenchyma 
longer than expected, yielding a late parenchymal enhancement phase (Blomley et al., 
1998; Leen, 2001; Quaia et al., 2002). Some of the second-generation contrast agents 
(Sonazoid®, Sonavist®) have similar effects, giving a late parenchymal enhancement 
phase possibly due to selective uptake by reticuloendothelial Kupffer cells in the liver 
(Leen, 2001; Lim et al., 2004; Yanagisawa et al., 2007). It can, therefore, be debated 
whether these agents are pure blood pool agents or not.  
The gas component used in microbubbles is often a high molecular weight gas, 
because of the low solubility (slow diffusion rate) and long persistence of microbubbles, 
diminishing the amount of gas needed and providing a longer effective life for the 
microbubbles in circulation (Uhlendorf et al., 2000; Bouakaz et al., 2007). The most 






e.g. perfluorocarbons like perfluoropropane used in Definity®, or sulfur hexafluoride in 
Sonovue® (Package leaflet; FDA, 2001; EPAR, 2008). Both of these contrast agents 
provide strong enhancement and have excellent durability (Moran et al., 2000; 2002). 
The shell in the microbubbles can consist of various chemical compositions. They can 
be phospholipid (Definity®, Sonovue®) (Arditi et al., 1997; Rosenberg et al., 2002), 
polymeric (biopolymers, proteins) (Wheatley et al., 1990), non-ionic surfactants (Forsberg 
et al., 1997) or galactose-based (Albrecht et al., 2000; Wheatley, 2001). The main purpose 
of the shell is to stabilize the microbubble (Frinking et al., 1998; Moran et al., 1998; 
Bouakaz et al., 2007). It also has an effect on acoustic behavior and fate (Frinking et al., 
1998; Bouakaz et al., 2007; de Jong et al., 2009). For harmonic imaging, the shell needs to 
be flexible enough to allow the size of the microbubbles to change during oscillation, 
while also being stable enough to act as a protective shield, preventing microbubble 
breakage and allowing the microbubbles to circulate several times through the whole 
blood volume (Bouakaz et al., 2007). For the detection of liver tumors, uptake by the 
reticuloendothelial system is useful, and more rigid shells are needed (Wheatley, 2001). 
 
3.2.2. Microbubble behavior 
 
Microbubbles are modified by the ultrasound process (Uhlendorf et al., 2000). The size of 
the microbubbles changes in interaction with the ultrasound waves, making bubbles 
oscillate (Uhlendorf et al., 2000). The response of the microbubbles depends mainly on 
insonation (Moran et al., 2000; Emmer et al., 2007), which can roughly be estimated by 
MI. At a low acoustic power (low MI: ≈0.1-0.2), the microbubbles are stable and act as 
reflectors (Whittingham et al., 2007). At a medium acoustic power microbubbles start to 
oscillate (Chomas et al. 2002; Cosgrove, 2006).  When the acoustic power (acoustic 
pressure) is high (MI: >0.7), and the oscillations become very strong, the microbubbles 
rupture (Frinking et al., 1998; Bouakaz et al., 2005; Miller et al., 2007).  
Oscillation ability enables the use of microbubbles with a high range of ultrasound 
frequencies (1.7–50 MHz) (Greis, 2004; Goertz et al., 2007). Microbubble size and 
stability therefore have an influence on the selected transducer frequency and the type 
used (Gorce et al., 2000; Emmer et al., 2007; Goertz et al., 2007). The size of the bubbles 
is not constant (Emmer et al., 2007; Goertz et al., 2007). Each ultrasound contrast agent 
has its own reference range for the size of the microbubble (Definity®: 1-3 µm, 
Sonovue®: 1-10 µm), which is stated in the manufacturer’s information. 
3.3. Vascular anatomy and physiology of abdominal organs 
 
CEUS can be used to estimate organ perfusion, either to quantitate it or to detect focal 
perfusional changes. To be able to fully understand the perfusion quantification and the 
relationship in the perfusion between various abdominal organs, knowledge of vascular 






abdominal organs studied will be briefly discussed. In veterinary medicine, the cat is 
typically assumed to have a similar anatomy and physiology as the dog or other species. 
The vascular anatomy of larger abdominal vessels, such as the aorta, vena cava caudalis, 
and portal vein, and their branches, is known in the cat. However, the microvascular 
anatomy and physiology are not well known. Most of the studies concerning vascular 
physiology and microvascular anatomy have been performed with laboratory animals 
other than the dog and cat. The following sections refer mostly to the microvascular 
anatomy of the dog or humans, with a few exceptions, which are indicated in the text. In 





The liver is supplied by the hepatic artery (20%), which branches from the celiac artery, 
and portal vein (80%), which drains blood from the cranial and caudal mesenteric, splenic, 
and gastroduodenal veins. The hepatic artery divides further into 3-5 branches at the hilus 
of the liver. These branches supply accordingly the right liver lobes (lateral, medial, 
caudate), parts of the right medial, quadrate, and left medial lobes, and parts of the left 
medial and quadrate lobes and the entire left lateral lobe. The portal vein branches after 
the liver hilus into 2-3 branches: the right, middle, and left portal branch. The portal veins 
and hepatic arteries run in parallel in the liver, branching repeatedly. The terminal 
branches, portal venules, and hepatic arterioles supply blood into the hepatic sinusoids, 
where they partially anastomose. The blood from the sinusoids is collected in central 
venules draining into the hepatic veins and vena cava (Schummer et al., 1981b; Evans et 
al., 1993).  
The portal vein receives blood from several abdominal organs, including the 
gastrointestinal tract, pancreas, and spleen. The major contributants of the portal vein are 
the gastroduodenal vein, splenic vein, and caudal and cranial mesenteric veins (Schummer 
et al., 1981b).  
The microcirculation in the liver comprises all intrahepatic vessels smaller than 300µm 
in diameter. Thus, it includes portal venules, hepatic artetrioles, sinusoids, central venules, 




The kidneys are supplied by renal arteries branching directly from the abdominal aorta. 
Renal artery bifurcates into dorsal and ventral branches, each of which divides further into 
a number of interlobar arteries (2-7), before or after the renal hilus. At the 
corticomedullary junction, the interlobar arteries divide into numerous arcuate arteries, 
interlobular arteries, and afferent arterioles entering the glomerulus, glomerular arterioles, 
efferent arterioles leaving the glomerulus (at the level of the outer medulla) and entering 
the capillary network before draining back to the venous system (Figure 1) (Schummer et 








Figure 1 The vasculature of the kidney: renal artery (1), renal vein (2), interlobar artery and 
vein (3), arcuate artery and vein (4), and interlobular artery and vein (5). Ureter (6), 
kidney cortex (7), and medulla (8). 
The microcirculation is divided in cortical, outer, and inner medullary systems. The 
difference in the perfusion between the kidney cortex and medulla is that the cortex is 
supplied by arterial blood, whereas the blood coming to the medulla (efferent arterioles) 
has already passed through the capillary system, in the glomerulus at the corticomedullary 
junction, or parts of it (Schummer et al., 1979; Pallone et al., 1998). There are shunting 
vessels directly to the medulla supplied by periglomerular pathways, but the extent of 




The spleen is supplied by the splenic artery, which arises from the celiac artery. The major 
draining vein is the splenic vein, which drains into the portal vein. The splenic artery 
branches into three to five branches; to the pancreatic, left gastroepiploic, splenic and 
short gastric arteries.  The spleen has 25 smaller splenic arterial branches that pass through 
the hilus, terminating into the reticular meshwork (Schummer et al., 1981a).  
The spleen is divided functionally into white and red pulp, and blood vessels (Schmidt 
et al., 1983) (Figure 2). In cats, the white pulp consists of mainly lymphatic nodules, 
whereas the major role of the red pulp is to store, concentrate, and filter erythrocytes, 
lymphocytes, and monocytes (Song et al., 1971). In cats, no direct arterio-venous 
connections have been found in the spleen, contrarily to dogs, and thus, the spleen of cats 
is said to be non-sinusoidal (Schmidt et al., 1982; 1983) (Figure 2). The blood flows from 
arteries to veins through the reticular meshwork of the red pulp. The pulp venules are non-
anastomosing, and receive flow freely from the reticular meshwork via open ends and 
fenestrations (Levesque et al., 1976; Schmidt et al., 1983) (Figure 2). Furthermore, the 














et al., 1971; Levesque et al., 1976) to be divided into three compartments. Thus, a 
definitive picture of the circulatory pathways through the spleen of the cat is difficult to 
obtain because the microvascular bed is not formed from a system of closed vessels 
(Schmidt et al., 1983). 
 
 
Figure 2 Structure and vasculature of the spleen. The microvascular structure is in 
magnification:  red pulp (R), white pulp (W) with, arteries (A), and veins (V). 
3.3.4. Pancreas 
 
The pancreas is supplied by cranial and caudal pancreaticoduodenal, splenic, and gastro-
duodenal arteries, which arise from the celiac artery, with the exception of the caudal 
pancreaticoduodenal artery, which arises from the cranial mesenteric artery. The left part 
of the pancreas is supplied by branches from the splenic, cranial pancreaticoduodenal and 
gastroduodenal arteries, all arising from the celiac artery (Schummer et al., 1981a). 
The vascular structure of the pancreas comprises a fine reticular network of vessels 
arranged in an intralobular vascular pattern. Within the interstitial spaces, larger 
interlobular vessels are evident. Microvascular segments of pancreatic perfusion are 
arranged in a densely meshed network of nutritive capillaries, afferent arterioles, and post-
capillary venules (Geboes et al., 2001; Schaser et al., 2005). 
Arterial arcades are formed between the major supply arteries, and numerous 
anastomoses are present within the substance of the pancreas. Within the pancreas, the 
arterial branches form an interlobular plexus in the connective tissue of the interlobular 






form a fine reticular network supplying individual islets of Langerhans and then continue 
to adjacent acini. The veins in the pancreas correspond in general to the arterial pattern. 
They drain into the portal venous system behind the neck of the pancreas (Schiller et al., 
1975; Geboes et al., 2001; Schaser et al., 2005). 
 
3.3.5. Small intestine and mesenteric lymph nodes 
 
The small intestine is mainly supplied by the cranial mesenteric artery and its branches. 
The duodenum is supplied by the cranial and caudal pancreaticoduodenal arteries, the 
jejunum by 12-15 jejunal arteries, and the ileum by accessory cecal and ileocolic arteries, 
and mesenteric ileal branches of jejunal arteries (Schummer et al. 1981a). The mesenteric 
lymph nodes are supplied by jejunal arteries (Schummer et al., 1981b). 
The arteries in the mesenterium divide and anastomose several, forming arcades. The 
last of these forms a marginal artery along the small intestine. The marginal artery is 
defined as the artery closest to, and parallel with, the wall of the intestine (Geboes et al., 
2001). From the marginal artery, blood reaches the intestine via short, straight branches or 
the vasa recta. The vasa recta penetrate the external muscle layers of the bowel wall to 
reach a profusely anastomotic submucosal arterial plexus, from which arterioles for the 
mucosa, submucosa, and muscular layers originate. The lymphoid tissue of the small 
intestine is supplied by the submucosal plexus through interfollicular arteries between the 
lymphoid follicles and through follicular arterioles originating from the interfollicular 
arteries. Venous drainage of each of the small intestinal capillary beds passes to the 
submucosal venous plexus, which anastomoses both longitudinally and circumferentially 
in the bowel wall. This plexus is drained by short veins, which penetrate the external 
muscle layers, chiefly along the mesenteric margin and then pass to branches of the 
superior mesenteric vein in the mesentery. The superior mesenteric vein receives venous 
drainage of the distal duodenum, jejunum, ileum, appendix, caecum, ascending and 
transverse colon, and the right gastro-epiploic vein draining the stomach, before joining 
the splenic vein to form the hepatic portal vein (Geboes et al., 2001). 
The mesenteric lymph nodes, also called jejunal lymph nodes, consists of a varying 
number (2-5) of nodes, and are located in the root of the mesentery on both sides of the 
jejunal arteries and veins in the cat (Schummer et al., 1981b). These nodes drain lymph 
from the entire small intestine and the body of the pancreas and from the colon and rectum 
via caudal mesenteric lymph nodes (Schummer et al., 1981b). 
3.4. Safety of CEUS 
 
3.4.1. Safety of USCAs  
 
The gas inside the microbubbles is biologically so inert and stable that it will not react 






from the lungs by exhalation (Morel et al., 2000; FDA 2001; Greis, 2004; EMEA, 2005). 
The shell is either metabolized by the liver or used directly as a component in cell 
membranes (Morel et al., 2000; Greis, 2004). Eventhough there are certain risks and 
adverse effects related to CEUS (Dijkmans et al., 2005; van Camp et al., 2007), they are 
mostly considered to be not serious (Blomley et al., 2007).  
Compared to other imaging modalities using contrast, USCAs are very safe to use, 
even in patients with liver or kidney failure and in trauma patients (Jäger et al., 2004; Leen 
et al., 2004; Correas et al., 2006). Side-effects are rare and when they do occur are mostly 
mild and transient (Miller et al., 2000; Morel et al., 2000; FDA, 2001; EMEA, 2005). 
Cardiac arrhythmia and premature ventricular contractions are possible with contrast-
echocardiography when high MI is used and the heart is imaged at end-systole (Miller et 
al., 2000; FDA, 2001; Cosgrove, 2004; Jäger et al., 2004; Leen et al., 2004; EMEA, 2005). 
In experimental studies performed with rats using high MI (> 0.8), transient myocardial 
damage was seen as an elevation in troponin T, however, no histopathological evidence of 
cellular damage or inflammation was noted (Chen et al., 2002). In addition, the study 
design (USCA dose, MI, triggered imaging, transducer frequency, size of patient) 
exaggerated the extent of myocardial damage in CEUS; this level of damage would not be 
expected in clinical use (Chen et al., 2002). With USCAs, there is a mild and transient risk 
of embolus formation as a sequela of bubble aggregation (Miller et al., 2000; Cosgrove, 
2004). This has little, if any, clinical significance unless the patient has congenital 
ventricular septal defect, which allows blood to circulate from left to right, therefore 
allowing the blood and possible emboli to reach brain circulation (Cosgrove, 2004). 
Ironically diagnosing these shunts was one of the original indications of cardiac CEUS 
(Drobac et al., 1983). The microbubbles used nowadays have a short terminal half-life (5-
7 min) in the circulation (Morel et. al, 2000; FDA 2001).  Therefore brain damage due to 
gas emboli from microbubbles is unlikely to occur. In addition, the relatively small dose 
of the microbubbles in the circulation and the properties of microbubbles diminish the risk 
of bubble aggregation into almost zero (Cosgrove, 2004; Jäger et al., 2004). 
 
3.4.2. Adverse effects of CEUS  
 
The adverse reactions reported with USCAs are mostly mild and, transient (FDA, 2001; 
Piscaglia et al., 2006; Blomley et al., 2007; EPAR, 2005), occurring less commonly than 
with the use of contrast agents (containing either iodine or gadolinium) in other imaging 
modalities such as CT and MRI (Katayama et al., 1990a; 1990b; Miller et al., 2000; 
Kirchin et al., 2001; Cochran et al., 2002; Jäger et al., 2004; Leen et al., 2004; Piscaglia et 
al., 2006). No fatal adverse events have been reported in the clinical trials conducted to 
obtain marketing authorization for USCAs (FDA, 2001; EMEA, 2005), or in their clinical 
use in humans (Piscaglia et al., 2006), dog (O’Brien et al., 2004a; Ohlerth et al., 2008; 
Ivancic et al., 2009) or cats (Rademacher et al., 2008; Kinns et al., 2010).  
In medicine, the overall incidence of reported adverse effects of USCAs is less than 
10% (FDA, 2001; EPAR, 2005). The most commonly (1-10 %) reported adverse effects 
(headache, altered sensation at injection site, nausea, flushing, paraesthesia, and taste 






(Kitzman et al., 2000; Blomley et al., 2007; EMEA, 2005; EPAR, 2008; FDA, 2008). 
Moderate to severe adverse effects, requiring treatment, such as pain, nonspecific pain, 
pharyngitis, itching, rash, abnormal vision, dry mouth, dizziness, headache, hypotension, 
personality disorder, insomnia, respiratory disorders, nervousness, hyperglycemia, 
peripheral edema, eccymosis, and sensory-motor paresis, occur even less frequently (0,1-1 
%) (FDA, 2001; EPAR, 2005; 2008; Piscaglia et al., 2006; Blomley et al., 2007). 
However, similar symptoms as listed above have been reported also after iv injections of 
saline (Nanda et al., 2002). The overall reported rate of adverse effects in a post-marketing 
study of Sonovue® contrast agent by Piscaglia et al. (2006) was 0,125% and 0,0086% for 
serious adverse effects requiring treatment. The reporting rate of serious adverse effects 
has been reported to be higher with cardiac imaging (0,019%) than with abdominal 
imaging (0,0078%) (Blomley et al., 2007). 
The ultrasound itself has been proven to cause some thermal effects on tissues 
(Abramowicz et al., 2008; O’Brien et al., 2008). Adding USCA increases these thermal 
effects (Prosperetti et al., 1991) as a function of acoustic power, focal depth and USCA 
dose (Wu, 1998). This should be taken into account, when imaging sensitive tissues like 
the brain or eye with or without contrast agents. However the body system is well 
protected from oxidative injury caused by free radicals and cell damage produced by 
cavitation. In addition, similar capillary ruptures that could occur after CEUS happen in 
the body system daily even without CEUS or basic ultrasound, e.g. due to coughing in the 
lungs or walking  in the soles of the feet. 
 
3.4.3. Contraindications  
 
The list of contraindications has undergone many changes in the last ten years. Both the 
European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) 
have changed their recommendations and list of contraindications for the use of USCAs in 
severely ill patients or cardiac patients. However, due to recent studies, both EMEA and 
FDA have later withdrawn some of the previously given contraindications of use (EMEA, 
2005; FDA, 2008) because they determined that, in some patients, the benefits for the 
diagnostic information that could be obtained through the use of USCAs may outweigh 
the risk for serious cardiopulmonary reactions, even among some patients at particularly 
high risk for these reactions. The contraindications removed by the FDA include: 
worsening or clinically unstable congestive heart failure, acute myocardial infarction or 
acute coronary syndromes, serious ventricular arrhythmias or high risk of arrhythmias due 
to prolongation of the QT interval, respiratory failure, severe emphysema, and pulmonary 
emboli or other conditions that cause pulmonary hypertension (FDA, 2008). 
The use of USCAs is in general contraindicated in patients with cardiac or pulmonary 
level right to left shunt, severe heart failure, recent acute coronary syndrome, unstable 
ischemic cardiac disease, pulmonary hypertension, uncontrolled hypertension or adult 
respiratory distress syndrome (Jäger et al., 2004; EMEA, 2005; Claudon et al. 2008). The 
cardiac contraindications listed above are opposed by many leading human cardiologists 
using CEUS (Blomley et al., 2007), since the true causal relationship with the previously 






studies has, not been indisputably shown (Cosgrove, 2006; Main, 2009; Blomley et al., 
2007). Furthermore, in a large post-marketing study, no increase in mortality risk has been 
associated with contrast-enhanced-echography in hospitalized patients (Kusnetzky et al., 
2008). 
No studies of the use of USCAs in pregnant or lactating animals or humans exist, and 
whether the gas component of USCA is excreted in milk is unknown (FDA, 2001; 
Cosgrove, 2004; Jäger et al., 2004; Claudon et al. 2008; EPAR, 2005). Animal studies 
have not indicated harmful effects with respect to pregnancy, embryonal or fetal 
development, parturition or postnatal development (EPAR, 2005). Furthermore, the 
microbubbles do not travel through the placenta in most species, due to the protective 
effects of the placenta and separate circulatory systems.  
 
3.4.4. Suspected pathophysiology of cellular damage in kidneys caused by 
CEUS in laboratory animals  
 
The potential of CEUS in causing kidney injury has been studied in rats, mice (Miller et 
al., 2007; 2008; 2009; Williams et al., 2007), and pigs (Jiménez et al., 2008; Miller et al., 
2010). Mild and transient effects on vasculature, such as microvascular damage in the 
kidneys, muscles, intestine, mesentery, lung, and heart, have been reported in small 
laboratory rodents experimentally (Miller et al., 2000; Dalecki, 2007; Williams et al.,  
2007; Miller et al., 2008). The imaging settings in these studies have, however, been quite 
different from those used in clinical scanning (Miller et al., 2000; Williams et al., 2007; 
Miller et al., 2008; 2009; 2010). Previous studies have indicated renal cellular injury, due 
to glomerular capillary rupture and hemorrhage (Wible et al., 2002; Miller et al., 2007; ; 
Williams et al., 2007; Miller et al., 2008; 2009; 2010). Clinically, this was detected as 
hematuria 5 min to 24 h post-CEUS (Miller et al., 2007; Williams et al., 2007; Miller et 
al., 2008). Histological analysis in these earlier studies showed glomerular capillary 
rupture, and in the proximal tubules, phagocytosis of erythrocytes and degeneration of the 
resorptive epithelium, indicative of acute tubular necrosis (Wible et al., 2002; Miller et al., 
2007; Williams et al., 2007; Miller et al., 2008; 2009; 2010). The effect was, however, 
transient, and significantly reduced by 24 h post-CEUS (Williams et al., 2007).  
The capability of CEUS to induce cellular damage has been shown to be highly 
dependent on transducer frequency, MI, duration of exposure, and USCA type and dose 
(Miller et al., 2000; Wible et al., 2002; Miller et al., 2007; Williams et al., 2007; Miller et 
al., 2008), most of these parameters are different from those generally applied to clinical 
patients. In these experimental studies, glomerular hemorrhage was induced only with 
lower frequencies (1.5-3.2 MHz) combined with high ultrasound exposure (MI of 0.78 – 
1.9, 1 to 9 min, intermittent imaging) and USCA infusion (Miller et al., 2008; 2009; 
2010). On the other hand, no glomerular damage could be induced with the higher 
transducer frequencies (5.0-7.4 MHz), not even with the highest allowed exposure (MI of 
1.9) in diagnostic ultrasound (Miller et al., 2008). The clinical significance of these effects 
is unclear in both human and veterinary medicine. Furthermore, no evidence of kidney 
damage was found in histological analysis in a recent study performed with pigs at a 






Sonovue® infusion, continuous imaging) after CEUS (Jiménez et al., 2008). However, in 
another recent study performed with pigs using high ultrasound exposure (transducer 
frequency 1.5 MHz, MI of 1.2 to 1.9, Definity® infusion, intermittent imaging), 
glomerular capillary hemorrhage was observed (Miller et al., 2010). The differences 
between these two studies (Jiménez et al., 2008; Miller et al., 2010) are in ultrasound 
exposure (MI, scanning time), the USCA used, and imaging protocol (continuous vs. 
intermittent).  
 
3.4.5. Detection of renal cellular injury   
 
To detect an acute and transient kidney injury that might be potentially induced by CEUS, 
sensitive biomarkers are needed. Many urinary enzyme activities have been reported to 
increase earlier than blood urea nitrogen (BUN) or serum creatinine concentration, 
suggesting that they are sensitive early indicators of the risk of acute kidney injury in cats 
(Hardy et al., 1985; Jepson et al., 2009), dogs (Greco et al., 1985; Heiene et al., 1991; 
Rivers et al., 1996; Clemo, 1998; Coca et al., 2008) and human (D’Amico et al.,  2003; 
Westhuyzen et al., 2003). Previous studies have documented the use of a variety of urinary 
activities, such as N-acetyl-β-D-glucosaminidase (NAG), gamma-glutamyl transferase 
(GGT), and alkaline phosphatase (ALP), in association with acute kidney injury (AKI) in 
various animal species, including cats (Hardy et al., 1985; Sato et al.,  2002b; Jepson et al., 
2009), dogs (Greco et al., 1985; Gossett et al., 1987; Heiene et al., 1991; Uechi et al., 
1994a; Grauer et al., 1995; Rivers et al., 1996; Palacio et al., 1997; Sato et al., 2002a), 
sheep (Garry et al., 1990; Raekallio et al.,  2010) and rats (Ogura et al., 1996). 
Urinary enzyme activities have been investigated in feline patients with drug induced 
AKI (Hardy et al., 1985), with other types of urinary disease (Sato et al., 2002b; Jepson et 
al., 2009), and with hyperthyroidism (Lapointe et al., 2008). The circadian variation 
(Uechi et al., 1998) and changes in renal enzyme activities in the kidney with age have 
also been evaluated (Kaler et al., 1978). The changes in the enzyme activities caused by 
AKI or chronic kidney disease in cats (Hardy et al., 1985; Sato et al., 2002b; Lapointe et 
al., 2008; Jepson et al., 2009) have been similar to those seen in humans (Bazzi et al., 
2002; Westhuyzen et al., 2003; Han et al., 2008) and dogs (Heiene et al., 1991; Uechi et 
al., 1994a; Rivers et al., 1996; Palacio et al., 1997; Clemo, 1998; Heiene et al., 2001; Sato 
et al., 2002a; Narita et al. 2005). However, in humans enzymuria has been reported to 
occur also as response to physiologic conditions or mild injury that does not precede AKI 
(D'Amico et al., 2003; Westhuyzen et al., 2003). NAG activities may also be increased in 
conditions without AKI (Iqbal et al., 1998; 2003; Kavukcu et al., 2002), for example in 
hypertension (Harmankaya et al., 2001), obesity, and diabetes (Corral et al., 1992; Fujita 
et al., 2002). Thus, when diagnosing active acute kidney cellular injury, it is important to 








4. Aims of the study 
The main objective of this thesis was to investigate the use of CEUS with varying 
ultrasound equipment, contrast-specific software, imaging protocols, and methods of 
measurements in cats.  Detailed aims were as follows: 
1. To develop an examination protocol for using abdominal CEUS and to evaluate the 
perfusion of normal abdominal organs (liver, kidney, spleen, small intestine, mesenteric 
lymph nodes, and pancreas) in healthy, anesthetized cats (I; IV). 
2. To determine the effect of the size and placement of the ROI on perfusion 
parameters (II). 
3. To study the effect of certain anesthetic agents on perfusion in the feline spleen with 
CEUS (IV). 










5. Materials and methods 
5.1. Test  animals (cats) 
The cats participating in our studies had earlier been used in other research projects 
assumed not to have an effect on the cats’ health. The protocols were approved by the 
Institutional Animal Care and Use Committee at the College of Veterinary Medicine, 
Kansas State University, and the College of Veterinary Medicine, University of Illinois. 
 
5.1.1. Group 1 
 
Ten clinically healthy, young (5-6 months), intact male (mean 4.0 kg, range 3.6-4.3 kg) 
domestic short-hair cats were included in the studies (I; II; IV group 1). The cats were 
purpose-bred and group-housed. Clinical examinations were performed on each cat with 
complete blood count (Hb, Hct, RBC, WBC, Plt, MCV, MCH) and serum biochemistry 
(ALP, ALT, AST, bile acids, total bilirubin, GGT, BUN, creatinine, Na, K, Mg, Ca, P, 
total protein, albumin) to exclude metabolic disease. Urinalysis was also performed 
(specific gravity, protein, pH, sediment, culture) to exclude infections and hematuria. A 
25-gauge intravenous catheter was placed in a cephalic vein during anesthesia. The 
indication for anesthesia was concurrent neutering for later adoption of the cats. 
 
5.1.2. Group 2 
 
Eight young to middle-aged (2-4 years), domestic short-hair cats were included in the 
studies (III; IV group 2). Five of the cats were neutered females, and three were neutered 
males.  The mean bodyweight was 5.2 kg (range 4.2-6.3 kg). The cats were purpose-bred 
and group-housed. At the start of this experiment, the animals were clinically healthy and 
had no ongoing treatments. Clinical examinations were performed on each cat with 
complete blood count (Hb, Hct, RBC, WBC, Plt, MCV, MCH), serum biochemistry (ALP, 
ALT, AST, total bilirubin, GGT, BUN, creatinine, Na, K, Mg, Ca, P, total protein, 
albumin), and urinalysis to confirm the health of the cats both before and after the study. 
Two of the cats had mildly elevated BUN and creatinine concentrations before and after 
the study, but none of the cats became clinically ill. The cats had permanent jugular (6 
cats) or saphenous (2 cats) catheters that had been placed 3-5 days before the study to 
facilitate collection of blood samples and injection of the USCA to avoid unnecessary pain 
and stress.  These catheters had been placed under sedation with 0.05 mg/kg of 
butorphanol, 0.04 mg/kg of medetomidine and 0.009 mg/kg atropine given 
intramuscularly (im). The effect of medetomidine had been reversed with 0.04 mg/kg 









5.2. Anesthesia of the cats 
5.2.1. Group 1 
 
Cats in group 1 were anesthetized for all of the imaging procedures (I; II; IV). They were 
pre-medicated with atropine (0.02 mg/kg sc), and sedated with acepromazine (0.06-0.1 
mg/kg sc) and morphine (0.25-0.5 mg/kg sc). General anesthesia was induced with 
diazepam (0.3 mg/kg iv) and ketamine (6 mg/kg iv). 
 
5.2.2. Group 2 
 
Cats in group 2 (III; IV) were first imaged awake (2awake) and later anesthetized 
(2anesth). The left kidney and spleen (2awake) were imaged while the cats were awake. 
After 48 h, the spleen was again imaged, but this time the cats were anesthetized (2anesth) 
to investigate the effects of anesthesia on CEUS of the spleen. The cats were first sedated 
with butorphanol (0.2-0.4 mg/kg im) and anesthesia was induced 15 min later with one to 
three boluses (adjusted by individual response) of propofol (1-3 mg/kg iv), and maintained 
with one to two additional boluses, as necessary to maintain the anesthesia. Imaging was 
started 10 min after the induction of anesthesia. After all imaging was completed, the cats 
were monitored clinically for 4 h for any possible side-effects. 




Cats were imaged using linear transducers of 8-15 MHz (group 1) or 3-11 MHz (group 2), 
with transmit frequencies of approximately 7 MHz (group 1) or 2.95 MHz (group 2), on 
ultrasound machines with contrast-specific softwares (CPS [Cadence Contrast Pulse ], 
Siemens Medical Solutions, and CnTI [Contrast Tuned Imaging], Biosound Esaote Inc.) 
available from Kansas State University, and University of Illinois, repectively. Both of 
these ultrasound systems are optimized for harmonic signal display and detection of 
nonlinear signals with either pulse sequencing (CPS) or subtraction (CnTI) techniques 












Table 1 Machine settings for each imaged organ: liver, left (lt) kidney, spleen, pancreas, 
small intestine (SI), and mesenteric lymph nodes (Mes Lnn). No time gain 
compensation (TGC) was used.  
Organ 
Cat 
group MI Power Frequency Frame rate Depth Focal zone  TGC 
Liver 1 0.32 16dB 7MHz 16Hz 4.5cm 2cm & 3cm no 
Kidney lt 1 0.32 16dB 7MHz 16Hz 4.5cm 2cm & 3cm no 
Spleen 1 0.32 16dB 7MHz 16Hz 4cm 2cm & 3cm no 
Pancreas 1 0.33 16dB 7MHz 16-21Hz 3cm 1cm & 2cm no 
SI, Mes Lnn 1 0.31 16dB 7MHz 16-21Hz 3cm 1cm & 2cm no 
         
Spleen 2 0.04 5% / 50-55% 2,95MHz 18-26Hz 2.2-2.9cm  1.5cm no 
Kidney lt 2 0.04 5% / 50% 2,95MHz 18Hz 3.6cm 2.5cm no 
         
         
 
 
5.3.2. Transducer positioning 
 
The hair was clipped over the ventrolateral abdomen (I; II; IV) or above the spleen and left 
kidney (III; IV). Alcohol and gel were applied to the skin and the transducers were 
manually positioned by the author during all imaging throughout the studies. Care was 
taken to keep the transducer in the same location in relation to the organ imaged and at 
approximately the same depth during the scanning; however, slight differences existed 
between the groups (1, 2) in the location and depth in the imaging of the spleen (IV). In 
group 1, images were collected from mid-body to the tail of the spleen. In group 2, images 
were collected from mid-body of the spleen, close to the branches of the splenic artery 
entering the hilus. 
 
5.3.3. Imaging parameters 
 
In group 1, the MI was maintained at a medium level (Table 1) depending on the depth of 
view. An intermediate MI was chosen for image optimization with the selected transmit 
frequency, machine system and contrast medium. Ultrasound scanning parameters, 
including depth, time gain compensation (TGC), overall gain, and focal zones, were 
standardized (Table 1). Two focal zones were placed at the level of or just below the organ 
imaged. The number and placement of focal zones were optimized for better image quality 
with the selected transducer frequency and imaging depth.  
Organs were imaged in the following order: liver, spleen, left kidney, pancreas, small 
intestine, and mesenteric lymph nodes. The left kidney, left lobe of the liver and the 
pancreas were imaged separately in the sagittal plane. The small intestine and mesenteric 
lymph nodes were imaged simultaneously in the transverse plane. A digital imaging series 
of 30 s with a frame rate of 16-22 Hz, depending on the depth of the organ imaged, was 






cats. Originally, this was thought to be sufficient to reach outflow of the contrast from 
each organ. This was, however, not the case with the spleen and kidney medulla. 
In group 2, a low MI was used (Table 1).  Adjustable scanning parameters were 
including depth, gain, output power, number and location of focal zones in relation to the 
target organ, standardized (Table 1). A 90-s digital imaging series with frame rates of 16-
25 Hz, depending on the depth and organ, was recorded for each contrast injection. 
 
5.3.4. Contrast agent administration 
 
Definity®-contrast medium was used in these studies. Definity® consists of 
octafluoropropane-gas-containing microbubbles encapsulated in a phospholipid shell. The 
contrast medium was prepared by shaking the vials with a mixing device according to the 
manufacturer’s instructions. All cats received multiple (group 1: one to two, group 2: three 
to six) bolus injections (0.1 ml) of contrast medium iv (group 1: cephalic vein, group 2: 
jugular or saphenous vein) followed by a bolus of 0.5 ml of heparin-saline. The injections 
were given in a standardized manner by the same person in each study. The time between 
the injections (from the end of injection to the beginning of the next) was approximately 2 
min (group 1) and/or until no contrast was visible (group 1: 2 min, group 2: 1-2 min). 
Between the injections an attempt was made to destroy the bubbles by continuous 
scanning of the imaged organ and cranial abdomen and aorta with fundamental ultrasound 
and output power adjusted to 100-80%, until background echogenicity was similar to pre-
injection levels, until no contrast was visible. In group 2, one of the cats had to be imaged 
on an additional day, due to poor image quality and non-co-operative behavior. 
5.4. Image analyses 
 
5.4.1. Quantitative analyses of the perfusion in the liver, spleen, kidneys, 
pancreas, small intestine and mesenteric lymph nodes (I; IV group 1)  
 
Standardized TICs were created on line from the raw imaging data (ACQ) in selected 
ROIs for each organ, representing the signal intensity (dB) in relation to time (s) (I; II). 
The data were then exported and evaluated with an external computer using commercial 
software (Excel and Prism) to obtain functional perfusion parameters. Care was taken not 
to include any adjacent tissues (mesentery, falciform fat) or larger vessels inside the ROI. 
In the pancreas, small intestine, and mesenteric lymph nodes, the size of the ROI was 
chosen so that it covered the organ parenchyma as well as possible. However, the ROI was 
limited in size when avoiding large vessels near the organ of interest. Artifactual data, 
such as data from adjacent tissues introduced within the ROI during respiratory motion, 
were removed. The placement of the ROI is illustrated in Figure 4 (yellow).  In the liver, 
the placement of the ROI was left from midline, but the placement varied slightly between 






parameters chosen for analysis were according to Du et al., (2008) and Waller et al., 
(2007) as follows:  
• Arrival time (AT, [s]), defined as the time point when contrast level rises above 
baseline in the TIC, followed by a further rise (10% above baseline). 
• Time to peak intensity (TTPinj, [s]), measured from the end of the injection, 
defined as the time when intensity peaks following AT. 
• Baseline intensity (BI, [dB]), defined as the signal intensity at AT. 
• Peak intensity (PI, [dB]), defined as maximal signal intensity at TTPinj. 
• Time to peak intensity from the initial rise (TTPinr=TTPinj-AT, [s]). 
• Wash-in rate (Wi, [dB/s]) was calculated from the data subset between 10% 
above baseline to 90% of the peak intensity. This avoided the use of toe and 
shoulder in the time intensity curve. The data were tested for linearity by 
assessment of significance (p<0.05) and R-square (> 0.7) to validate the use of 
linear regression analysis. 
• Wash-out rate (Wo, [dB/s]) was calculated from the data subset between 90% 
below the peak intensity, where all subsequent points continued to decline, 
until 20% above the previous baseline value or until the final point measured 
(liver, spleen, renal medulla). The data were then regressed for linearity. 
A detailed illustration of the perfusion parameters is presented in Figure 3. 
 
The liver, kidney cortex, and medulla were imaged in all ten cats. In addition the 
pancreas, small intestine, and mesenteric lymph nodes were imaged in eight cats (8/10). 
Wash-out was calculated in 9/10 cats in the kidney medulla due to a very gradual sloping 
within the 30-s time interval. In one cat, the wash-out of the kidney medulla was gradual 
and was not measured within the first 30-s. Wash-out in the pancreas was calculated in 
7/10 cats due to poor image quality in one cat. In 8/10 cats, data for the liver and kidney 
cortex were obtained by averaging two injections. In the other two cats, the second 
recording and corresponding TIC was rejected because of poor image quality. In kidney 
medulla (10/10), pancreas (8/10), small intestine (8/10) and mesenteric lymph nodes 







Figure 3 Time-intensity curve (TIC) example from kidney cortex. For more details, see the text.  
5.4.2. Different methods of measuring or estimating perfusion  
 
The perfusion measurements estimated using three slightly different methods were 
compared by the same trained person: 1) ultrasound video combined with TIC, 2) 
numerical data from the TIC, and 3) visual estimation from the ultrasound video. The 
perfusion parameters (AT, TTPinj, BI, PI) obtained with different methods, were compared 
with each other statistically. In the visual estimation from the video, only timing 
parameters (AT, TTPinj) could be estimated and compared with other methods. The 
comparisons were made in data obtained from the kidney cortex (cat group 1). These data 
have not been previously published. 
 
5.4.3. Effect of ROI size and location on measurements of perfusion in 
CEUS (II) 
 
Standardized TICs were drawn from selected ROIs in the cortex of each kidney. The data 
were manually edited by simultaneously analyzing the ultrasound images and TICs frame 
by frame to remove any false peaks and troughs from the TIC of due to respiratory 
motion. The functional perfusion parameters were chosen according to previous reports 
(Du et al., 2008; Waller et al., 2008) as follows: AT, [s]; TTPinj, [s]); BI, [dB]; PI, [dB]; 
TTPinr=TTPinj-AT, [s]; Wi, [dB/s]; and Wo, [dB/s]. 
To study the effect of the location of the ROI on obtained values, three similar-sized 
(oval, length 0.5 cm) ROIs were placed in a row on the near field cortex at approximately 
the same depth (1-1.5 cm, Figure 5. ROI 1). The amount of subcutaneous and abdominal 






To examine the effect of ROI placement on depth direction (ROI 2), three additional ROIs 
were placed in a column (at depth 1 cm, 1.5-2 cm, and 2-2.5 cm) on the cranial cortex of 
the left kidney (Figure 4). Due to the round shape of the cat kidney, these ROIs could not 
always be placed exactly in a straight vertical line. To investigate the effect of size, three 
differently sized ROIs of length of approximately 0.3 cm, 0.6 cm, and 1.2 cm were placed 
in a row at the same depth in the near field cortex of the left kidney. The depth of the 
ROI’s in the size correlation was matched with the depth of the horizontal placement 
comparison (ROI 1).  
 
Figure 4 Placement of the ROIs 1 (grey), 2 (white) and 3(dark grey) in the kidney cortex.     
The same ROI 1a (= 2a) was used in ROIs 1 and 2. 
5.4.4. Estimation of perfusion patterns in the spleen (IV) 
 
The timing and grade of both heterogeneity and homogeneity of the spleen were estimated 
in a standardized manner by the same trained person in all groups (1, 2awake, 2anesth). 
This grading was developed to estimate the perfusion patterns visually due to differences 
in the machinery and therefore in the quantitative analysis of the perfusion between the 
groups. The person estimating the timing and grade was blinded from the identifier 
information on the ultrasound clips, and the clips were presented in randomized order. The 
grade (1-4) of heterogeneity was estimated at the time when the spleen was most 
heterogeneous as follows (Figure 5): grade 1, slightly mottled, less-enhanced areas not 
well defined; grade 2, moderately heterogeneous, regional, small (diameter < 0.5 cm) non-
enhanced areas; grade 3, heterogeneous, regional, medium-sized (0.5 < diameter ≤1.0 cm) 
non-enhanced areas; grade 4, strongly heterogeneous, regional, large (diameter > 1 cm) 
non-enhanced areas. The grade of homogeneity (1-3) was estimated when the spleen was 
the most homogeneous as follows (Figure 6): grade 1, entirely homogeneous; grade 2, 
almost homogeneous; grade 3, obviously mottled, not homogeneous
1a=2a



































































































































































































































5.5. Sample collection and laboratory analyses (III) 
Blood samples were collected from jugular or saphenous catheters already placed for 
another research protocol. Blood was collected before and 48 h after contrast ultrasound. 
Urine samples were collected by cystocentesis before and 4 h and 48 h after contrast 
ultrasound. Ultrasound guidance was used, when the bladder was small or difficult to 
palpate. The baseline samples (urine and blood) were taken 5 days before beginning the 
study to allow the bladder to recover from possible bleeding post-cystocentesis. 
Urine composition (specific gravity, pH, protein, creatinine, sediment to detect 
hematuria) and urine enzymatic activities (ALP, GGT, NAG) were analyzed. To correct 
for variations in urine flow, the enzyme activities (U/l) were normalized for urinary 
creatinine concentrations (g/l) and given as a ratio (U/g). RBC counts from the sediment 
were classified for statistical analysis into four separate classes: Class 0, no red blood cells 
visible (0 RBCs/hpf); class 1, 1 to 10 RBCs/hpf; class 2, 10 to 100 RBCs/hpf; and class 3, 
more than 100 RBCs/hpf.  
The blood samples and urine were kept in a refrigerator until centrifuged (3300 rpm, 5 
min) at 4°C to remove cellular components and debris. All of the samples were processed 
within 4 h of collection. Serum biochemistry measurements were performed with a 
clinical chemistry analyzer (Roche Hitachi 917 analyzer 37°C, Roche Diagnostics 
GmbH). Urine was first analyzed with a dipstick (Chemstrip, Roche Diagnostics GmbH), 
and urine specific gravity was determined by refractometry. Urine protein was determined 
with benzethonium chloride reaction and creatinine with alkaline picrate method (Roche 
Hitachi 917 analyzer 37°C, Roche Diagnostics GmbH, calibrated for urine). The urine was 
then centrifuged and the sediment underwent microscopic examination. Urine enzymatic 
activities were analyzed with a clinical chemistry analyzer (Roche Hitachi 917 analyzer 
37°C, Roche Diagnostics GmbH). The rest of the urine samples were frozen at -80°C to 
await further urine NAG assays. NAG activity was measured with a commercial kit 
(NAG-kit, Roche) using a colorimetric method one month after the urine collection. 
5.6. Statistical analyses 
Statistical analyses were conducted with statistical software (SPSS and Statistix) by the 
author with statistician consultation. Data calculated for each perfusion parameter 
included mean values and standard deviation. Bonferroni’s correction was used for the 
obtained p-values. Statistical siginificance was set at p<0.05. 
 
Analysis of variance with repeated measurements was used to compare the following: 
1. The perfusion parameters of each organ (liver, spleen, left kidney, pancreas, small 
intestine, mesenteric lymph nodes) between cats (I). 
2. The perfusion parameters between organs or organ groups (sub-group of small 






3. The effect of the location and size of the ROI with the functional perfusion 
parameters (AT, TTPinj, BI, PI, Wi) on the kidney cortex (II). 
 
Student’s t-test with two-tailed p-value was used to analyze or compare the following: 
1. The variance within and between cats in the liver and renal cortex (I). 
2. The perfusion parameters between organs (pairwise testing) (I). 
a.  Liver and kidney cortex 
b.  Pancreas and small intestine   
c.  Kidney cortex and liver, pancreas, small intestine 
d.  Small intestine and pancreas, mesenteric lymph nodes 
3. The perfusion parameters between the differently perfused splenic areas (group 1) 
(IV). 
4. The time to the first appearance of the contrast in the spleen (ATv) and the time to 
the spleen becoming heterogeneous (TTHeinj) or homogeneous (TTHoinj), each 
parameter assessed visually between groups 1 and 2anesth, and within cats in 
group 2 with (2anesth) and without (2awake) anesthesia. 
 
Student’s one-sample t-test was used to evaluate the difference between two different 
injections (repeatability) in the liver and kidney cortex data (I). 
 
Pearson’s correlation test was used to evaluate similar tendencies in the perfusion 
parameters between separate organs within the same cat (I). 
 
Coefficient variation was used to estimate the amount of internal variation in the 
perfusion parameters (I). 
 
Analysis of variance with randomized complete block was used to separate the effect 
of the depth and the size of the ROI from the variance between the cats and from the 
statistical noise in the PI (II). 
 
Homogeneity of variance was tested from the PI in the depth and size comparison 
using Levene’s test, O’Brien’s test, and the Brown and Forsythe test (II). 
 
Friedman’s test (non-parametric) was used to compare 
1. The perfusion parameters between the different methods (video and TIC, TIC only, 
visual estimation from the video only). 
2. The urinary measurements taken before and 4 h and 48 h after CEUS (III). 
 
Wilcoxon’s Signed Rank test (non-parametric) was used to compare 
1. Pairwise post hoc testing of perfusion parameters between the different methods 
(video and TIC, TIC only, visual estimation from the video only). 







3. Pairwise testing of blood measurements taken before and 48h after contrast 
ultrasound (III). 
 
Fischer’s exact test (non-parametric) was used to compare the grades of heterogeneity 
and homogeneity of the spleen both between groups 1 and 2anesth and within the cats 







6.1. Normal organ perfusion (I) 
The qualitative, visual assessment of the perfusion patterns in each imaged organ was 
evaluated from the ultrasound video clips. The quantitative assessment of the perfusion 
parameters was measured as signal intensity vs. time from selected ROIs acquired from 
the generated TICs (Table 2).  
 
6.1.1. Perfusion in the liver, spleen, kidneys, pancreas, small intestine and 
mesenteric lymph nodes (I; IV group 1)  
 
The enhancement of the different organs varied in time and pattern (Figure 7). Achieving 
contact between the linear transducer and the cat was somewhat difficult and required a 
moderate amount of pressure, especially when imaging the liver. The image quality was 
therefore not always optimal for the entire liver. In general, the image was considered 
more heterogeneous in the liver than in the other organs (Figure 7b), with the exception of 
the kidney medulla and the less perfused areas of the spleen. After injection of the contrast 
agent, there was an immediate marked enhancement of the hepatic arteries and portal 
veins. This was followed by a more gradual enhancement of the liver parenchyma. 
Enhancement of the spleen was very heterogeneous at the beginning of imaging 
(Figures 5 and 7c, Table 2). In most of the cats, the splenic parenchyma was enhanced in 
two or three phases (Figures 5 and 7c, Table 2): The large splenic vessels enhanced 
rapidly and intensely. This was followed by enhancement of the parenchyma surrounding 
these vessels (Figure 5, area A; Figure 7c, black ROI), followed by a more gradual 
enhancement of the remainder of the spleen (Figure 5, area B; Figure 7c, white ROI). 
Enhancement of the two differently enhanced splenic areas (A and B) reached equivalent 
intensity at approximately 20-25 s (Figure 7c, TIC). At this same time, the early enhanced 
areas (A) were already in wash-out phase (Figure 7c, TIC). 
The kidney parenchyma enhanced in two phases (Figure 7a, Table 2): The contrast 
arrived first in the cortex (Figure 7a, black ROI), followed by a more gradual and sparsely 
spotted enhancement of the medulla (Figure 7a, white ROI). The enhancement of the 
cortex and medulla reached almost equal intensity at 30 s; by this time, the cortex was 
already in wash-out phase (Figure 7a, TIC).  
The pancreas, small intestine, and mesenteric lymph nodes all enhanced early and 
very intensely immediately after the large supplying vessels (Figures 7d and 7e). Keeping 
the ROI in the middle of the scanned area, thereby avoiding larger vessels and adjacent 
























































































































































































































































































































































































































































   































































































































































































































































































































































































































































































































































































































































6.1.2. Differences in the perfusion between organs  
 
The results of the statistical analyses from the comparison of perfusion parameters 
between organs are presented in Table 2. The differences between the kidney cortex and 
medulla were statistically significant in all perfusion parameters. This was considered to 
be unrelated to the small difference in the depth of the ROI between the cortex and 
medulla. This was further supported by visual assessment; the large difference in the 
enhancement between the cortex and medulla was considered to be more obvious than the 
mild attenuation of the signal intensity at the distal kidney cortex. The differences between 
the differently perfused splenic areas A and B were significant in all perfusion parameters, 
except AT. In the sub-group of the small intestine, lymph nodes, and pancreas, no 
significant differences were observed. The liver differed from the kidney cortex and 
pancreas in all of the perfusion parameters. Between the liver and small intestine, a 
significant difference arose in all parameters, except BI and PI. Moreover, a significant 
correlation emerged between the small intestine and lymph nodes in AT (r=0.943), BI 
(r=0.734), and TTPinj (r=0.856), and between the kidney cortex and, small intestine in AT 




The intra-individual variation between the two separate injections (in the liver and kidney 
cortex data) was smaller than the interindividual variation. The numerical data from 
separate injections are presented in Table 3. In the liver data, however, a significant 
difference appeared in the BI between the injections (p=0.014). 
Table 3 Perfusion parameters from separate injections in the kidney cortex and liver 
presented as mean (±SD). The asterisk (*) indicates a significant difference 
between parameters. 
  AT (1.) BI (1.) TTPinj (1.) PI (1.) TTPinr (1.) 
Kidney 
cortex 4.01 (0.50) 10.60 (2.56) 6.01 (0.81) 32.39 (5.95) 2.00 (0.69) 
Liver               5.63 (2.50) 9.03 (3.26)* 9.72 (3.46) 29.51 (3.36) 4.08 (1.95) 
   AT (2.) BI (2.) TTPinj (2.) PI (2.) TTPinr (2.) 
Kidney 
cortex 4.01 (0.64) 10.70 (3.42) 6.04 (0.62) 32.25 (4.72) 2.03 (0.41) 
Liver               6.56 (2.56) 11.22 (3.56)* 10.00 (3.34) 28.57 (3.60) 3.44 (1.00) 
 
 
6.1.4. Comparison of different methods in measuring or estimating 
perfusion  
 
A significant difference emerged in AT between the different methods (p=0.012) in the 
kidney cortex data (Table 4), when comparing the visual estimation with the combination 






was smaller than the difference in the accuracy between the methods (visual estimation 
only 1 s, other methods 0.01 s).  The differences in AT and PI between TIC analysis and 
the combination of visual estimation of video and TIC reached statistical significance 
(p=0.063 and p=0.055, respectively). 
Table 4 Perfusion parameters presented as mean (±SD) from the method comparison in 
the kidney cortex data. The asterisk (*) indicates a significant difference between 
parameters. 
Method AT (s) BI (dB) TTPinj (s) PI (dB) 
TIC 4.01 (0.48) 10.60 (2.56) 6.01 (0.81) 32.39 (5.95) 
TIC+Video 3.76 (0.65)* 10.39 (2.59) 6.60 (0.55) 33.30 (5.45) 
Video 4.25 (0.46)*   6.69 (0.80)   
6.2. Importance of location and size of ROI (II) 
 
Subjectively, the image quality appeared optimized and uniform in the near-field kidney 
cortex. Attenuation was observed by visual estimation in the far-field cortex. A significant 
difference was found in the peak intensity of the ROIs for both depth (Figure 8; p=0.027) 
and size (Figure 9; p=0.026). The mean PI decreased with increasing depth and increasing 
size of the ROI. The variance in PI was homogeneous between ROIs of varying depth and 
size (p>0.22 and p>0.46 respectively).  However, there was no significant difference in the 
PI between the ROIs placed in a row in the near-field cortex (p=0.861) (Table 5). 












































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



















   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   


















   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   


















   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   














A significant difference was present in BI (p=0.006) at the time of the first contrast 
agent appearance with varying placement of the ROIs in a row in the near field cortex 
(Table 5).  
No significant difference emerged within the set of ROIs 1-3 in the following 
parameters: AT, PI, and Wi (Table 5). 
 
 
Figure 8 Mean (±SD) of peak intensity (PI) as a function of ROI depth. Differences in the mean 




Figure 9 Mean (±SD) of peak intensity (PI) as a function of ROI size. Differences in the mean 














































6.3. Effect of anesthesia on splenic perfusion (IV) 
 
The numerical results describing the perfusion of the spleen in group 1 are displayed in 
Tables 2 and 6. The results of the statistical analyses from the comparison of the awake 
and anesthetized cats are presented in Table 7. The differences between the differently 
perfused splenic areas A and B in group 1 were statistically significant in all perfusion 
parameters, except AT (Table 6). The time to first appearance of contrast medium (AT 
visual) in the spleen was significantly different between awake and anesthetized cats 
(2awake and 2anesth) (p=0.0307), but not between cats with different anesthesia protocols 
(groups 1 and 2anesth) (Table 7). The frequencies of the heterogeneous and homogeneous 
grades in the groups are presented in Figures 10 and 11. The least homogeneous grade 3, 
and the most heterogeneous grade 4 are overrepresented in group 2anesth (Figures 10 and 
11). This indicates a difference in both the homogeneity and heterogeneity of the spleen 
between the groups, however, no significant difference was found between the groups in 
the heterogeneity or homogeneity grades. 
Table 6 Perfusion parameters calculated from the time-intensity curves (TICs) for the cat 
spleen in group I, with differently perfused splenic areas A and B are presented as 
mean (±SD). Significant differences (p<0.05) in perfusion parameters between the 
different areas (A and B) are indicated with an asterisk (*).   
AT (s) TTPinj (s) BI (dB) PI (dB) Wi (dB/s) Wo (dB/s)
Spleen A 3.90 (1.22) 7.77 (1.40) * 9.87 (2.07) 32.50 (4.41) * 6.95 (2.80) * - 0.52 (0.12)
Spleen B 4.02 (1.45) 25.10 (2.24) * 9.26 (2.00) 25.90 (5.42) * 0.81 (0.25) *
 
Table 7 Numerical results estimated visually in all groups (1, n=10, 2, n=8) are presented 
as mean (±SD). The first contrast arrival (ATv), the time to heterogeneity after the 
injection (TTHeinj), and the time to the spleen becoming the most homogeneous 
after injection (TTHoinj) are shown.  Significant differences (p<0.05) in 
parameters between cat groups are indicated with an asterisk (*).   
Parameter AT v (s) TTHe inj (s) TTHo inj (s) Anesthesia 
Group 1  4.20 (0.63)  5.20 (0.79)  28.30 (2.87)  Yes 
Group 2awake  3.88 (0.64) * 4.63 (1.06)  30.75 (8.07)  No 









Figure 10 Heterogeneity grades of the spleen between groups. The grade of heterogeneity was 
estimated visually when the spleen was the most heterogeneous (≈ 5 s). The cats were 
anesthetized in group 1(n=10) and group 2anesth (n=8), and awake in group 2awake 
(n=8).  
 
Figure 11 Homogeneity grades between groups. The grade of homogeneity was estimated 
visually when the spleen was the most homogeneous (≈ 30 s). The cats were 
anesthetized in group 1(n=10) and group 2anesth (n=8), and awake in group 2awake 








































6.4. Effect of CEUS on kidneys (III) 
The results of the laboratory values (urinalysis and biochemistry profile) are presented in 
Tables 8 and 9. There was a statistically significant increase in urine NAG (p=0.006) 
ratios when compared before and 48 h after contrast ultrasound (p=0.012), but not 
between before and 4 h after CEUS (p=0.123) (Table 8). No significant changes occurred 
in the mean GGT or ALP ratio, urine protein-creatinine ratio, pH, specific gravity, or urine 
red blood cell counts. A significant decrease in BUN concentration (p=0.024) (Table 9). 
No significant changes occurred in the rest of the analyzed blood constituents. Two of the 
cats had mildly elevated BUN and creatinine concentrations before and after the study, but 
none of the cats became clinically ill. One of the cats was later euthanized due to intestinal 
lymphoma and the rest of the cats were clinically healthy one year later.  
 
Table 8 Results of urinalysis of the eight cats presented as mean (±SD). Significant 
differences between the parameters are indicated with an asterisk (*, p<0.05). 
Urinary measurements were compared 3-5 days before (baseline), 4 h and 48 h 
after CEUS. RBC counts from sediment were classified as follows: Class 0=0 
RBCs/hpf; class 1=1 to 10 RBCs/hpf; class 2=10 to 100 RBCs/hpf; and 
class=more than 100RBCs/hpf.  
Parameter Unit Baseline 4 h  48 h 
NAG ratio U/g 0.53 (0.35)* 0.75 (0.22) 1.43 (0.59)* 
GGT ratio U/g 13.51 (3.28) 15.02 (5.35) 18.19 (6.4) 
ALP ratio U/g 10.05 (9.16) 4.15 (5.27) 9.24 (7.86) 
Prot ratio g/g 0.12 (0.04) 0.10 (0.03) 0.12 (0.08) 
RBC (0-3) 1.00 (1.07) 0.75 (1.17) 1.25 (1.28) 
pH    7.0 (1.07) 6.38 (0.74) 6.25 (0.46) 
Sp   1.052 (0.01) 1.051 (0.01) 1.041 (0.02) 
 
Table 9 Results of serum biochemistry measurements of the eight cats presented as mean 
(±SD). A significant decrease in blood nitrogen is indicated with an asterisk (*, 
p<0.05) 
Parameter Unit Baseline 48 h  
Crea mg/dL 1.70 (0.32) 1.78 (0.29) 
Urea mg/dL 26.05 (7.39)* 23.48 (8.41)* 
Alb g/dL 3.46 (0.16) 3.43 (0.10) 








The cat is commonly assumed to be similar to a small dog in veterinary medicine with, 
respect to anatomy and physiology, although it is well-known that this is not always the 
case. Little is known about the use of CEUS in feline patients. Many elderly cat patients 
can be kidney compromised, and thus, safety issues are an important area of research in 
feline medicine. Oftentimes, feline patients need to be sedated or anesthetized; the effect 
of anesthesia on CEUS is therefore an equally important area of research. The main aim of 
this thesis was to describe normal organ perfusion in several feline abdominal organs and 
to establish an imaging protocol specifically suitable for cat patients to serve as a reference 
for later clinical applications of CEUS. The study approach chosen allowed a broad-
spectrum protocol to investigate various aspects of CEUS, and simultaneously opened 
several options for future experimental and clinical research. 
Multiple factors have an influence on the contrast-enhancement of an organ (Porter et 
al., 1997; Lucidarme et al., 2003; Sonne et al., 2003; Li et al., 2005; 2006; Tang et al., 
2007; Mulé et al., 2008; Mulvana et al., 2010). Therefore, thorough assessment of normal 
organ perfusion and understanding of all of the complex factors influencing perfusion 
were considered as important first steps prior to conducting clinical studies. Shedding light 
on the methodology of CEUS and elucidating the basic physics behind it. In CEUS as well 
as in other diagnostic modalities, there is always a certain learning curve involved in 
before reaching the full diagnostic value of the modality, which further emphasizes the 
importance of knowing what is typical for CEUS breed-specifically. 
7.1. Normal organ perfusion (I; IV) 
In Studies I and IV, typical perfusion patterns for each imaged organ were evident. 
Perfusion in the abdominal organs of the cat seemed similar to that of the dog based on 
earlier studies (Ziegler et al., 2003; Nyman et al., 2005; Kamino et al., 2006; Ohlerth et al., 
2007a; Waller et al., 2007; Nakamura et al., 2009; Bigliardi et al., 2011; Jiménez et al., 
2011). In general, the abdominal organs in the cat seemed to enhance earlier with contrast 
than in the dog. The enhancement of the spleen was very heterogeneous at the beginning 
of imaging and it lasted longer than expected from previous reports in dogs (Ohlerth et al., 
2007a; Nakamura et al., 2009). However, the cats were imaged under general anesthesia 
with several anesthetic agents, which may have had an effect on the organ perfusion.  
Differences in the functional perfusion parameters between the different organs or 
differently perfused areas of the kidney and spleen (I; IV), can mostly be explained by 
physiological differences between the vascular structure and blood flow of the organs 
(Levesque et al., 1976; Hollenberg et al., 1979; Schmidt et al., 1983; Christensen et al., 
1993; Geboes et al., 2001; Pallone et al., 2003; Potdevin et al., 2006; McCuskey et al., 
2008). Differences between the organs in the parameters describing the timing (AT, 






differences in the afferent vessel systems, vascular structure, and the blood flow (Evans et 




The liver, which was always imaged first, showed a similar pattern (I) as seen in other 
species (Ziegler et al., 2003; Nyman et al., 2005; Quaia et al., 2006; Wilson et al., 2007; Li 
et al., 2006). However, TTPinj seemed to be earlier in the cat (10 s) than in the dog (23-35 
s) (Ziegler et al., 2003; Nyman et al., 2005; I). The image quality was not always optimal 
for the entire liver for two reasons (I). First, the contact between the skin of the cat and the 
linear probe almost always required a moderate amount of pressure, and despite the 
pressure there was sometimes lack of contact. This might cause problems, such as a lack 
of compliance, and thus increased motion and decreased transducer contact in a non-
anesthetized animal. Second, the frequency of the probe and the dosage of the contrast 
media were so high that noticeable attenuation occurred in the far field (4 cm depth).  
The relatively large variation detected in liver perfusion parameters (I) is likely to be 
due to small differences in regional blood flow caused by the complex vascular structure 
of the liver (Li et al., 2005; 2006; McCuskey et al., 2008), dual blood flow (Lueck et al., 
2008), and the close proximity of the diaphragm. This was also considered to be the 
reason for the increased heterogeneity visible in both the image (during the first 10-15 s) 
and in the TIC for the entire 30 s. The slope of both the wash-in and wash-out phases was 
slight as is typical for the liver in other species as well (Ziegler et al., 2003;  Li et al., 
2005; Nyman et al., 2005; Metoki et al., 2006; Wilson et al., 2007).  The broad-shouldered 
shape of TIC is most likely due to the dual blood flow from the hepatic artery and portal 
vein (Evans et al., 1993; Lueck et al., 2008), causing constant flow of microbubbles from 
two vascular systems independently from each other. Furthermore, the gentle and 
heterogeneous parenchymal and hepatic venous late phase enhancement, is likely to be 
affected by the travelling of the microbubbles through several capillary beds in the lungs, 
gastrointestinal tract and liver sinusoids (Evans et al., 1993; McCuskey et al., 2008).  
It has been shown previously, that the placement of the transducer and specifically 
placing the ROI in different liver lobes, has had an effect on the observed perfusion 
parameters (Li et al., 2006).  The placement of the ROI could not be kept constant 
between the cats in our study (I), and this may have caused overestimation of the variation 
in the perfusion parameters in the liver data. However, the moderate heterogeneity 
observed in the perfusion pattern of the liver is reportedly less than the differences 
between healthy liver and focal neoplastic changes observed by both qualitative and 
quantitative CEUS (Quaia et al., 2006; Wang et al., 2007; Wilson et al., 2007). Therefore, 
it is probably not clinically important when comparing focal perfusional changes, but it 











7.1.2.  Kidney 
 
The kidney cortex showed a homogeneous, early, and intense enhancement, followed by a 
more gradual and heterogeneous enhancement of the medulla (I), which was similar to 
other species (Pietra et al., 2005; Waller et al., 2007; Potdevin et al., 2006) and a previous 
study in cats (Kinns et al., 2010). However, in our study, TTPinj (6 s) seemed to be earlier 
in the kidney cortex (I) than in previous studies in cats (13 s) (Kinns et al., 2010) and dogs 
(13 s) (Waller et al., 2007). The kidney medulla enhanced sparsely, first at the periphery, 
followed by gradual enhancement of the inner portions (I), according to the blood flow 
direction (Hollenberg, 1979; Pallone et al., 2003). Nevertheless, TTPinj (22 s) in the 
medulla in our study (I) corresponded better to the earlier studies in both cats (26 s) 
(Kinns et al., 2010), and dogs (21 s) (Waller et al., 2007). However, the results from these 
previous studies (Waller et al., 2007; Kinns et al., 2010) are not entirely comparable with 
ours due to differences in the anesthetic agents and protocols used (IV). Moreover, 
possible differences may have existed in the placement and size of the ROIs (II); these 
differences have been shown to have an effect on perfusion parameters (Schlosser et al., 
2001; Verbeek et al., 2001; Potdevin et al., 2006; II). Furthermore, the placement of the 
ROIs was not reported in the study by Kinns et al. (2010). In addition, the vascular 
structure has been demonstrated to vary within the kidney cortex (Hollenberg, 1979; 
Verbeek et al., 2001; Pallone et al., 2003) and therefore differences in the TTPinj may be 
expected if the placement and size of the ROI are very different. 
The marked difference in the perfusion, detected with CEUS, between the kidney 
cortex and medulla (I)  corresponds well with physiology (Hollenberg, 1979; Christensen, 
1993; Pallone et al., 2003), and agrees with previous studies in other species (Claudon et 
al., 1999; Potdevin et al., 2006; Waller et al., 2007) as well as in cats (Kinns et al., 2010). 
The difference in perfusion between the cortex and medulla may be slightly overestimated 
in our study (I; II), because the ROIs drawn in the cortex and medulla were not exactly at 
the same depth. This was due to the small size of the cranial pole of the cat kidney. The 
depth of the ROI has been shown to have an impact on the obtained signal intensities due 
to attenuation (Mulé et al., 2008; II). The effect of attenuation was, however, visually 
estimated to be less than the obvious difference in perfusion between the kidney cortex 
and medulla. Therefore, respiratory and other motion artifacts occurring in the TICs at the 
cranial pole of the kidney cortex, could lead to an even more fluctuating TIC, and 
therefore, to greater variations in the perfusion parameters (II). In addition, if the ROIs 
were drawn at the same depth (cortical ROI in the cranial pole of the kidney), the size of 
the ROIs would have been different between the cortex and medulla. This has been shown 
to have an influence on perfusion parameters as well (Schlosser et al., 2001; II).  
The delayed onset of the signal and the longer time required to reach PI (gentler slope) 
apparent in the kidney medulla (I) compared with the cortex can, therefore, be explained 
simply by the differences in vascular structure; the majority of the blood flow into the 
medulla comes from the cortex through a capillary network (Hollenberg, 1979; 
Christensen, 1993; Pallone et al., 2003). The volume and velocity of the blood flow in the 
medulla are much less than those in the cortex, and some of the microbubbles have already 






variation detected in the perfusion parameters of the medulla (I) was also consistent with 
earlier studies in dogs (Waller et al., 2007), pigs (Claudon et al., 1999), and rabbits 
(Potdevin et al., 2006) and can be explained by the unique vascular structure of the inner 
and outer medulla (Pallone et al., 2003).  The slower and lower level of blood flow, and 
therefore, the smaller amount of circulating microbubbles cause more variation in the 
detected intensities in relation to time (Potdevin et al., 2006), partially due to vascular 
heterogeneity in the medulla and partially to a greater impact of motion artifact in the TIC. 
Some of this variation may, however, represent true variation between individuals. Further 
studies are needed to estimate its importance in clinical patients with renal disease 
affecting the medulla. 
 
7.1.3.  Spleen  
 
Our results indicate that the early parenchymal phase of CEUS splenic perfusion is 
heterogeneous in healthy cats (IV). The contrast seemed to arrive to the spleen in the cat 
faster (3-4 s) than in dogs (13 s) (Ohlerth et al., 2007a; IV). However, this is likely to be 
due to differences in the ROI sizes, which can be expected from the bigger variance in the 
perfusion parameters in the study by Ohlerth et al. (2007a); The late enhancing areas in the 
spleen were probably included in the ROI used to calculate the perfusion parameters in the 
their study. This could explain the slower contrast enhancement, both later arrival of the 
contrast (AT) and longer time (25 s) required for the spleen to reach peak enhancement 
(TTPinj) in the dog (Ohlerth et al., 2007a), relative to the early enhancing areas of the 
spleen in the cat  (TTPinj 8 s; IV). Whether these differences are truly species specific or 
due to differences in the assessment of the perfusion parameters warrants future studies.  
The difference detected in our study in the perfusion between the two differently 
perfused splenic areas (IV) corresponds well with previous research from splenic 
physiology (Song et al., 1971; Levesque et al., 1976; Schmidt et al., 1982; 1983). 
However the splenic perfusion in the cat was observed to be more heterogeneous (IV) than 
in humans (Catalano et al., 2005) or dogs (Ohlerth et al., 2007a; Rossi et al., 2008; 
Nakamura et al., 2009). Morphological and kinetic studies of the spleen have shown 
differences in the circulatory pathways between species (Levesque et al., 1976; Schmidt et 
al., 1983). The nonsinusoidal architecture offers one explanation for the regional delayed 
enhancement of the splenic parenchyma in our study (IV). However, differences in 
methodology impair the direct comparison of separate studies in the vascular physiology 
of the spleen. Furthermore, the effect of physiological stimuli causing splenic contraction 
or dilatation has not been compared between species. Possible species-specific differences 
in the blood flow and in the physiological reactions of the spleen may offer an explanation 
for regional differences in enhancement of the spleen in the cat observed in our study (IV). 
It may thus explain the longer time to reach homogeneity in the spleen of cats (28 s, in 
group 1) relative to dogs (approximately 23 s) (Ohlerth et al., 2007a; Rossi et al., 2008; 
Nakamura et al., 2009). However, the different USCAs and imaging protocols used in the 








7.1.4.  Pancreas, small intestine, and mesenteric lymph nodes  
 
The pancreas, small intestine, and mesenteric lymph nodes all showed an early, intense 
and uniform enhancement (I), as could be expected in organs receiving all of their blood – 
and  therefore also microbubbles – directly from afferent arteries, similarly to other 
species (Rubaltelli et al., 2004; D'Onofrio et al., 2007; Mitsuoka et al., 2007; Gashen et al., 
2010; Jiménez et al., 2011). In comparison with perfusion of medial iliac lymph nodes in 
dogs (Gashen et al., 2010), both mean AT (cat 4 s vs. dog 6 s) and TTPinj (cat 6 s vs. dog 
12-14 s) occurred earlier, however, mean PI (cat 24 dB vs. dog 29 dB) was less, in the 
mesenteric lymph nodes of the cats (I). This could be due to differences in the afferent 
vessels, imaging protocol, USCA dose and injection technique, or anesthesia status. 
Alternatively this might a purely species-specific phenomenon, since a similar tendency 
was noticed in other organs in our study (I). In addition, the small intestine and mesenteric 
lymph nodes receive all and the pancreas at least parts of its blood from the cranial 
mesenteric artery (Schummer et al., 1981a), and thus, similarities in perfusion could be 
expected based on similarities in circulation. These organs were imaged one after another, 
and thus the number of USCA doses given was different in the pancreas than in the small 
intestine and mesenteric lymph nodes (I). However, no differences in the perfusion pattern 
were observed between the organs (I). Furthermore, the perfusion parameters in the small 
intestine and mesenteric lymph nodes were highly correlated with each other (I). This also 
strengthens our results of the repeatability of CEUS between the first and second 
injections in the liver and kidney cortex (I). In the future, CEUS may prove useful in the 
assessment of focal and even diffuse changes of these organs, for example in the 
assessment of pancreatic lesions and, focal mural masses in the intestines or in the search 
of malignant lymph nodes. Additionally, these organs may even offer a reference for each 
other, in cases where no normal organ tissue within one of these organs can be found. 
However, it must be emphasized that some diffuses disease processes, such as lymphoma, 
may involve both the small intestine and mesenteric lymph nodes, and thus no differences 
would be expected in the enhancement between the organs.  
 
7.1.5. Repeatability  
 
Repeatability of obtaining perfusional parameters was good in both the liver and renal 
cortex (I). The difference between the two injections in BI in the liver data (I) could be 
due to variation caused by respiration, the complex dual and sinusoidal blood flow (Li et 
al., 2005; Metoki et al., 2006), differences in blood flow between separate areas of the 
liver (Li et al., 2006) or true baseline variation due to bubble uptake by the sinusoids or 
bubble saturation (Li et al., 2005). The difference observed in the BI (I) was, however, 
considered clinically non-significant, since it was markedly less than the reported relative 
difference in the PI between healthy and neoplastic liver tissue (Hohmann et al., 2003; 
Bartolotta et al., 2004; Wilson et al., 2007). 
In the renal cortex, no significant difference was found between the separate injections 
in any of the parameters (I). This can be due to the highly vascularized, well-organized 






et al., 1979; Christensen et al. 1993). However, the sequence of the injections was 
different between the liver and renal cortex (I), as the liver was the first organ imaged 
(first and second injections) and the cats had already been given repeated injections before 
the kidney was imaged (fifth and sixth injections). Therefore a small difference in BI 
between cats could have been hidden by a small amount of residual microbubbles as the 
effect of several contrast injections on the perfusion parameters and specifically on BI has 
not been previously reported.  
These results indicate that no significant differences in the perfusion parameters 
existed between two subsequent injections with the scanning intervals used in this study 
(I). In addition, it seems that the differences would mainly have an effect on the BI (I), and 
thus, have the greatest effect between the first and second injections, and almost no effect 
on the following injections, since an attempt was made between each injection to break 
any residual bubbles. Using multiple injections for each imaging, the comparability 
between the injections may thus be expected to increase, as the baseline intensity before 
the injection can be expected to be more similar than between the first and second boluses. 
In the future, comparison of the first, second, and third injections per organ, in both awake 
and anesthetized animals in a standardized protocol, might improve the understanding of 
the differences between separate USCA boluses. 
 
7.1.6. Comparison of different methods in measuring or estimating 
perfusion   
 
The results from the statistical analyses suggest that the visual estimation of AT from the 
video only can be considered less sensitive as an analyis method than TIC numerical data 
and the combination of visual estimation from the video and TIC together. This is 
probably due to differences in the accuracy of the methods. First, visual estimation from 
the video has a less sensitive scale (1 s vs. 0.01 s), and second, it is highly dependent on 
the observer’s vision and experience. For clinical use, the three analysis methods can be 
considered equally accurate and can be used correspondingly, especially when estimating 
TTPinj, in which no statistically significant differeneces were found between the analyzing 
methods. The differences in the PI and AT between the analysis of TIC numerical data and 
the combination of visual estimation from the video and TIC together, suggest that small 
differences can occur in the perfusion parameters between these methods. However the 
size of the difference (1dB, < 1s) indicates that the differences are unlikely to be clinically 
relevant. However, the data and TIC from the kidney cortex is very homogeneous and 
smooth, and no larger fluctuations occur in the TIC (Figure 3), which would not be the 
case with the kidney medulla or spleen. Therefore, different results could be expected in a 
comparison of these methods, when analyzing an organ with more heterogeneous 
perfusion and large fluctuations in TIC. This must be taken into account when taking these 






7.2. Importance of location and size of ROI (II) 
The well-organized, although complicated vascular structure in the kidney cortex of the 
cat, provides a good experimental model for quantification of tissue perfusion.  In our 
study, we found that both the depth and the size of the ROI have an effect on the PI (II). 
The deeper or larger the ROI, the lower the PI (II). This is consistent with previous reports 
(Sonne et al., 2003; Mulé et al., 2008). The interaction between microbubbles, anatomic 
structures, and the ultrasound beam is complex, and artifacts complicating the assessment 
of perfusion may occur, especially in quantitative analyses (Qin et al., 2007; Mulé et al., 
2008; Mulvana et al., 2010), although CEUS has excellent sensitivity for microbubble 
detection and good spatial resolution. The signal intensity is a sum of multiple factors, 
most of all a sum of ultrasound-induced microbubble behavior. However, multiple factors 
can have an influence on the detected signal intensity. These include local differences in 
the replenishment of the contrast agent due to respiratory and other movement; differences 
in attenuation, both from the microbubbles and the tissues; and unequal destruction of the 
circulating microbubbles in the whole field-of-view, all of which may vary slightly in the 
round kidney cortex (Sonne et al., 2003; Mulé et al., 2008). In our studies (I-IV), 
respiratory and other movement artifacts were estimated to be the most difficult to control, 
especially in awake cat patients, which can become tachypneic due to stress, causing false 
peaks and troughs and increased fluctuations into TIC. 
The focal zones were consistently placed in the far-field kidney cortex. Despite this, 
the image quality appeared optimal in the near field-cortex (II). This was most likely due 
to attenuation in the far field image. The energy of the ultrasound beam and the intensity 
of tissue contrast enhancement are not constant in the entire imaging field, even in a 
homogeneous tissue (Sonne et al., 2003; Mulé et al., 2008; Tang et al., 2010). The amount 
of microbubble destruction and attenuation is dependent on the peak negative pressure 
focused on the bubbles (Porter et al., 1997; Sonne et al., 2003; Tang et al., 2007), which 
can be expressed as MI multiplied by the square root of the ultrasound frequency (Miller 
et al., 2007). The energy of the ultrasound beam is optimized by the ultrasound machine in 
the focal zone. The amount of energy and therefore attenuation in the imaging field 
depends mostly on a combination of detection technique (Sonne et al., 2003),  transducer 
frequency (Porter et al., 1997; Tang et al., 2007), frame rate (Porter et al., 1997), MI 
(Porter et al. 1997; Sonne et al. 2003), dosage (Li et al. 2005) and type of contrast agent 
(Sonne et al., 2003), amount of overlying tissues between the imaged organ and the 
transducer (Mulé et al., 2008), distance of the ROI from the focal zone, and the 
replenishment rate of the bubbles (Lucidarme et al., 2003; Sonne et al., 2003). 
Furthermore, the cats were given multiple contrast agent injections, which may have 
caused some level of microbubble saturation, increasing the effect of attenuation in the far 
field (Skyba et al., 1994; Wei, 2001a; Li et al., 2005). However, in our study (I-IV) the 
circulating residual microbubbles were broken with B-mode ultrasound between each 
injection, which can be assumed to prevent or at least diminish the risk of microbubble 
saturation. Furthermore, no significant differences were found in the perfusion parameters 






The kidney cortex is a highly vascularized organ (Hollenberg et al., 1979; Christenssen 
et al., 1993), and therefore, the number of circulating microbubbles is abundant. We 
observed relatively high attenuation in the far-field compared with the near-field kidney 
cortex (I; II). This was thought to be caused by the high transducer frequency (7 MHz), 
intermediate MI, and placement of the focal zone area in the distal part of the image in 
combination with microbubble characteristics of the kidney cortex. This is consistent with 
previous results from USCA Definity® attenuation characteristics with varying transducer 
frequencies (Goertz et al., 2007). 
The size of the ROI was related to the mean PI (II). Increasing the size of the ROI did 
not, however, decrease the variation in the observed PI (II). Variance between the 
differently sized ROIs was homogeneous in statistical analysis (II). The small differences 
in the standard deviation were considered to be caused by noise. This finding conflicts 
with a previous study (Schlosser et al., 2001), where increased reproducibility in 
evaluation of replenishment kinetics, in time and intensity parameters, and decreased 
variation associated with increased ROI size were found in porcine kidneys. However, 
their study (Schlosser et al., 2001) was ex-vivo, using explanted pig kidneys in a perfusion 
unit with settings different from ours (II), including continuous infusion of contrast agent, 
a different transducer frequency and type and larger size differences between the ROIs, 
which make direct comparison inaccurate. All of these factors have an effect on obtained 
intensity values and image quality (Porter et al., 1997; Sonne et al., 2003; Li et al., 2005; 
Tang et al., 2007; Mulé et al., 2008; Talu et al. 2008). Our explanation for the difference 
we found in the ROI size comparison, is that a larger ROI in the set includes 
microvascular differences (affecting inflow, outflow and peak intensities), which are not 
contained in a smaller ROI. Another possibility is that some non-cortical tissue may have 
been included in the largest ROI. 
No statistically significant difference emerged in any perfusion parameter as a function 
of ROI placement in a row in the near-field cortex (II). This also supports our conclusion 
of ROI depth and size being the most significant factors affecting signal intensity. 
Baseline signal intensity reflects the number of microbubbles in the ROI in the 
beginning of the wash-in phase. The number of circulating microbubbles (Li et al., 2005), 
and respiratory and other movement artifacts that cause heterogeneity in the TIC (Mulé et 
al., 2007) have an influence on the BI. Therefore, the small fluctuations observed in BI in 
our study (II) are not considered representative of true changes in the kidney perfusion.  
No timing parameters were affected by the relative position of ROIs (II), suggesting 
that the injection protocol is the main factor affecting the timing parameters. These timing 
parameters may therefore be used clinically, as long as the injection technique is 
standardized. The magnitude of the measured differences in mean PIs between the ROIs 
(II) was, however, not large enough to be deemed clinically important. The magnitude of 
change within individual animals based on depth was greater (II), but not considered 
clinically important based on the visual image analysis. No quantitative analyses have 
been done in veterinary medicine with naturally occurring lesions. The lesion 
characterization with CEUS is based on the subjective visual assessment of the lesion 






in naturally occurring lesions and diffuse parenchymal changes in various organs and 
disease processes in veterinary patients.  
7.3. Effects of anesthesia (I; IV) 
Vascular reactions and organ perfusion cannot be easily estimated through 
cardiopulmonary and blood flow measurements alone. The cardiopulmonary and 
hemodynamic effects of various anesthetics in cats and other species have been evaluated, 
but none of the studies have investigated the effects of the anesthetic combinations used in 
our studies (I, IV). Therefore, we can only speculate on the impact tha the anesthesia used 
in our study to assess normal organ perfusion had on each separate organ. Furthermore, 
the time with respect to the equilibrium of the anesthesia was highly different between the 
first imaged organ (liver) and the last imaged organs (pancreas, small intestine, mesenteric 
lymph nodes), decreasing the comparability of the results between these organs.  
 
7.3.1. Effect of anesthesia on splenic perfusion (IV) 
 
Our findings suggest that anesthesia increases heterogeneity in the spleen of cats in CEUS 
(IV).  The spleen is commonly observed to become dilated during surgery and the basic 
ultrasound examinations performed on sedated or anesthetized animals. Many anesthetic 
agents are known to dilate the spleen and decrease systemic blood pressure, both of which 
can decrease splenic blood flow. Kinetic research of red cell wash-out from perfused 
spleens in rats and cats has revealed that the circulatory routes change radically depending 
on whether the organ is dilated or contracted (Groom et al., 1971; Levesque et al., 1981).  
Previous studies have investigated the effects of anesthesia on the size of the spleen 
(Hubbell et al., 1982; O'Brien et al., 2004b; Wilson et al., 2004) as an indicator of splenic 
congestion.  
Acepromazine and thiopental have been shown to cause an ultrasonographic 
measurable increase in spleen size in dogs (O'Brien et al., 2004b). In another study, the 
size of the spleen measured surgically was reported to be the largest with ketamine-
diazepam or thiopental-induced anesthesia (Wilson et al., 2004). In both earlier studies, 
the spleen was smallest in dogs treated with propofol (O'Brien et al., 2004b; Wilson et al., 
2004), suggesting that propofol induces the mildest dilatation of the spleen relative to the 
other anesthetic agents (thiopental, acepromazine, ketamine, diazepam) investigated. 
Conversely, in a previous study by Hubbel et al. (1982), xylazine was found to decrease 
dose-dependently the size of the spleen via α-adrenergic receptors. In our study (IV), drug-
induced splenic congestion may have exaggerated the heterogeneous perfusion patterns in 
the splenic CEUS. Contrary to previous results of splenic congestion in dogs (O'Brien et 
al., 2004b), butorphanol and propofol caused more heterogeneity in our study (IV), than a 
mixture of atropine, acepromazine, xylazine, diazepam, ketamine, and morphine. 
Interestingly, in an earlier report, propofol was described to decrease the TTPinj of the liver 
in dogs (Nyman et al., 2005). This may have been due to a propofol-induced increase in 






in the perfusion parameters in the study by Nyman et al. (2005) was large, and this may 
have had an effect on the comparisons.  
The doses of the anesthetic agents are known to have a major role in the hemodynamic 
effects. Thus, the effects of anesthetic agents can vary depending on the dosage and be 
different in separate organs such as the liver and the spleen. Whether the increase in 
heterogeneity of the splenic perfusion in our study (IV) was due to propofol alone, or was 
a synergistic effect of propofol and butorphanol warrants further investigation. In our 
study (IV), the depth and duration of anesthesia varied between groups (1 and 2anesth), 
which may have had an influence on the congestive effects of the spleen (Kramer et al., 
1951; Guntheroth et al., 1963). Furthermore, the interaction of several simultaneous 
stimuli and different drugs on splenic circulation can be considered unpredictable. Thus, 
the neutering procedure may also have had an impact on the hemodynamic balance via 
sympathetic stimulation, and even directly on the spleen in group 1. 
In our study, neither of the anesthesia protocols was found to influence the timing of 
heterogeneity or the time to the spleen being considered homogeneous, even when 
different equipment was used (IV). This further supports the evidence that the regional 
differences in perfusion of the spleen are due to physiological differences in the blood 
flow within separate regions of the spleen, which seem to be affected by the anesthesia 
protocols chosen. Probably the heterogeneity of the spleen was overestimated in the first 
study (group 1), when combinent injection anesthesia protocol was used (IV). However, as 
the comparison of the spleen in awake and anesthetized cats (groups 2awake and 2anesth) 
demonstrated, some degree of heterogeneity can be expected even in awake animals (IV). 
Anesthesia was, nevertheless, found to have an effect on the ATv in visual estimation 
between the cat groups 2awake and 2anesth (IV), as might be expected from anesthetic 
agents (propofol and butorphanol) that have negative effects on cardiac output, systemic 
vascular resistance, and mean arterial pressure (Muir et al., 2007). Similar effects can be 
anticipated in CEUS of other organs as well, when animals are sedated or anesthetized 
with anesthetic agents having similar effects on systemic circulation. Based on our results 
(IV), the impact of anesthesia should, however, be taken into account when imaging the 
feline spleen. Further studies are required to determine the clinical significance of the 
described findings, and to identify an optimal anesthesia protocol for use in veterinary 
patients in CEUS.  
7.4. Effect of CEUS on kidneys (III)  
The minor changes in the urinary NAG ratio detected in our study were considered 
clinically insignificant (III), because the maximal values were still within the range 
reported earlier for healthy cats (Uechi et al., 1994b; 1998; Sato et al., 2002b; Narita et al., 
2005; Lapointe et al., 2008; Brunker et al., 2009; Jepson et al., 2009) and less than has 
been reported to be indicative of AKI in dogs and cats (Heiene et al., 1991; Uechi et al., 
1994a; Sato et al., 2002a; 2002b). The magnitude of the change and the maximal values of 
the NAG ratio (III) were also lower than those found to be normal circadian variation in 






For consistency, sample collection, storage times and conditions, and analysis 
procedures were kept constant throughout our study (III). To avoid depletion of enzymes, 
ALP and GGT activities were measured within 4 h of urine collection, and NAG activity 
was measured after 1 month of storage at -80°C, which has been shown to be an 
acceptable practice in human medicine (Mueller et al., 1986). Urinary enzyme activities 
vary depending on storage conditions and analysis procedures (Gossett et al., 1987; 
Matteucci et al., 1994). Enzymes may become inactivated or unstable due to unfavorable 
conditions (Jung et al., 1982; Bondiou et al., 1985; Mueller et al., 1986; Matteucci et al., 
1991). However, the results from previous studies have been contradictory concerning the 
stability of urinary enzymes (Jung et al., 1982; Bondiou et al., 1985; Gossett et al., 1987; 
Pocsi et al., 1990; Matteucci et al., 1991; 1994). Major factors affecting enzyme stability 
include storage time and temperature. In addition, the quality of the urine sample and, the 
presence of blood cells, feces or bacteria may also have an effect on urinary enzyme 
activities (Raab, 1972).  
Urine enzyme-to-creatinine ratios in spot samples have been shown to correlate well 
with 24 h enzyme excretion (Gossett et al., 1987; Uechi et al. 1994b; 1998; Grauer et al., 
1995). Thus, collection of urine over a 24 h period was not considered necessary in our 
study, and cystocentesis was chosen as the method of urinary collection to maintain 
appropriate sample timing (III).  
Elevated urinary enzyme activities, specifically the NAG ratio, can either indicate 
tubular cellular damage in the kidney or reflect increased lysosomal cellular acitivity 
without cellular damage (Trof et al., 2006; Liangos et al., 2007). This further supports our 
conclusion that the mild rise after 48 h in NAG ratio (III) can be considered clinically of 
low importance with regard to detecting AKI. However, the number of animals in the 
study was small, and adverse effects with very low prevalence cannot be ruled out by this 
study. Nevertheless, no evidence of clinically significant kidney injury caused by CEUS 
using low to intermediate MI has emerged in earlier studies in humans or pigs (Piscaglia et 
al., 2006; Jiménez et al., 2008). A possible explanation for the contradictory results 
between previous studies is differences in imaging parameters. Further studies are 
therefore warranted to seek evidence of hematuria in clinical patients with impaired 
kidney function and CEUS with moderate MI (higher than used in Study III). 
While hematuria was detected in the samples, no significant increase in the degree was 
observed.  Collecting urine by cystocetesis potentially caused some bleeding (III), which 
might be a confounding factor, particularly considering the fact that hematuria may 
influence the urine enzyme-to-creatinine ratio (Grauer et al., 1995; Brunker et al., 2009).  
Cystocentesis was chosen as the method of urinary collection to be consistent (the same 
method each time), to avoid contamination with bacteria or enzyme additions from distal 
urinary tract or gonadal secretions, to avoid long urine collection periods that could cause 
depletion of enzyme activities, and to obtain the urine samples at exactly same time-points 
from each cat in relation to the contrast ultrasound (III). In rodents, hematuria after CEUS 
was significantly reduced by 24 h post-CEUS (Williams et al., 2007), and thus, our goal 
was to collect urine at certain timepoints before and after the expected decrease of possible 






The decrease in the BUN (III) was not considered clinically significant because 
possible kidney injuries are rather expected to increase BUN, if change at all, after 
contrast ultrasound. Also, the magnitude of change was considered to be clinically 
insignificant (III). Some of the cats had already mildly elevated BUN and plasma 
creatinine concentrations before the study, which was interpreted to be due to a protein-
rich diet during the study, catabolism (the cats had been given a slimming diet), and 
possible sub-clinical dehydration due to sedation for the permanent cathether placement 
(III). The BUN and creatinine concentrations did not increase in any of the animals, and 
the urine specific gravity was within normal limits, suggesting adequate kidney function. 
Both BUN and creatinine concentrations are considered to be poor markers for acute 
kidney injury because of renal reserve and numerous non-renal influencing factors (race, 
age, gender, muscle metabolism, protein intake, drugs, total body volume) (Watson et al., 
1981; Finco, 1997; Trachtenberg et al, 2007).  
Urine pH has been reported to have an influence on urinary enzyme activities (Jung et 
al., 1982; Uechi et al., 1994b; Brunker et al., 2009). At very low (4.7) or very high (8.0) 
urine pH-values, the enzymes may become inactivated or unstable (Jung et al., 1982). In 
our study, the urine pH was deemed suitable for urine enzyme activity measurements. In 
four of the animals studied, the urine pH was at its higher limits (pH 8.0) in the samples 
collected before CEUS. In a recent study on dogs (Brunker et al., 2009), urine pH was 
found to have an effect on urine GGT ratio, but not on urine NAG ratio. At pH ≥ 7.0, the 
mean urine GGT ratio increased almost twofold and the mean urine NAG ratio decreased, 
but not significantly (Brunker et al., 2009). Based on earlier studies, the baseline GGT 
activities may have been slightly underestimated by the relatively high urine pH in our 
study (III).  
In Study III the transducer frequency, contrast agent dosing and imaging settings were 
selected to mimic clinical conditions as realistically as possible. The study was performed 
under conditions intended to enable the occurrence of possible bioeffects based on results 
from earlier experimental laboratory studies (Williams et al., 2007; Miller et al., 2008). In 
previous studies, kidney injuries were observed with limited transducer frequency range of 
1.5-3.2 MHz (Miller et al., 2008). The threshold for occurrence of kidney injury has been 
observed to increase linearly with increasing MIs and frequencies (Miller et al., 2008). 
Excessive post-marketing surveys have revealed no such effect in man (Piscaglia et al., 
2006). Contrary to the studies performed by Miller et al. (2007; 2008; 2009; 2010) with 
rats, mice, and pigs, in a recent study no evidence of kidney damage emerged in either 
histopathological or laboratory analyses after CEUS of surgically exposed pig kidneys 
(Jiménez et al., 2008) with low to intermediate MI (0.2-0.5) and continuous imaging, but a 
high MI (1.9) was used to destruct residual microbubbles. In our study (III), the transducer 
frequency (3 MHz) and the imaging protocol and duration were similar, but the MI was 
lower than in the experimental studies during the actual imaging because of the clinical 
imaging settings. However, high MI (conventional B-mode) was used in Study III to 
destroy residual microbubbles before imaging the kidney due to prior imaging of the 
spleen, which may have further increased the potential risk of kidney cellular injury 
induced by CEUS. Therefore, CEUS can be assumed to be safe for use in imaging kidney 






modality for kidney-compromised patients compared with contrast-enhanced CT and 
MRI, which have proven to have harmful effects on kidneys (Mehran et al., 2006; Persson 
et al., 2006; Perazella, 2008). However, further studies are needed to assess the effects of 
CEUS in older animals and in patients with impaired kidney function. 
7.5. Limitations of the studies 
Little is known of the exact effects of anesthesia on the perfusion of various organs. 
Anesthesia has been previously reported to have an effect on perfusion parameters in 
CEUS of the liver (Nyman et al., 2005). In our study, the impact of multi-injection 
balanced anesthesia on organ perfusion can thus be considered a confounding factor in the 
assessment of normal organ perfusion (I), and warrants detailed investigations. 
Furthermore, the exact effects of the various anesthetic agents given in the study in each 
imaged organ as a function of time are not known. Despite anesthesia, equal perfusion 
parameters were found between the pancreas, small intestine, and mesenteric lymph 
nodes, indicating similar tendencies (I).   
In the comparison of splenic perfusion between cat groups, differences in the 
equipment, and thus, in the imaging protocol, and especially in the transducer frequency, 
were thought to be a confounding factor (IV). This may have influenced the subjective 
assessment of the image between groups 1 and 2 (IV). Estimation of homogeneity 
between groups 1 and 2 was difficult due to differences in the pixel size of the image 
between the machines. Estimation of enhancement homogeneity was, however, deemed an 
important aspect for future clinical studies. This raises a question of CEUS in general; 
how small can the focal changes be and still be visualized by CEUS, depending on the 
spatial image resolution, and therefore, mainly on equipment? In addition to the 
differences in the imaging, the cats in groups 1 and 2 were different in the splenic study 
(IV), which may hinder the comparison of the two differently anesthetized groups 1 and 2. 
However, the variation caused by differences between the two groups of cats can be 
considered a strength of the study since the major clinical finding, the heterogeneity of the 






8. Conclusions  
1. Our results indicate that CEUS can be used to estimate organ perfusion in cats, as in 
other species. The obtained baseline data in these studies can serve as reference values in 
the future assessment of clinical feline patients with kidney, liver, pancreatic, intestinal, or 
lymph node disease, or suspected vascular compromise. 
2. Quantitative CEUS, however, results very often in values that are not entirely 
comparable between studies. The results may vary due to the multiple factors affecting 
TIC. For perfusion quantification, the ROI should be selected based on where the 
enhancement is the most homogeneous and close to the focal zone range. The ROI size 
should be large enough to represent the tissue being analyzed, but small enough to avoid 
surrounding structures and vessels. When comparing two different ROIs in a patient with 
focal lesions, the ROIs should be placed at the same depth and be as similar in size as 
possible. Moreover, the timing parameters appear to be independent of ROI size and 
placement and are therefore applicable for clinical imaging. 
 3. Our study suggests that CEUS can be used for analyzing kidney perfusion in feline 
patients with minimal risks of cellular damage in kidneys. It is recommended that the 
exposure (contrast dosing, MI, scanning time) should be kept to the minimum required for 
diagnostic imaging. 
4. This study emphasizes that the estimation of focal perfusion defects in CEUS of the 
spleen in cats should be performed with caution, and only after disappearance of the initial 
heterogeneity. Based on our results, the effect of anesthesia should also be taken into 
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